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ABSTRACT
Microbes colonise all multicellular life, and the gut microbiome has been shown to influence a range of host physiological
and behavioural phenotypes. One of the most intriguing and least understood of these influences lies in the domain of the
microbiome’s interactions with host social behaviour, with new evidence revealing that the gut microbiome makes impor-
tant contributions to animal sociality. However, little is known about the biological processes through which the micro-
biome might influence host social behaviour. Here, we synthesise evidence of the gut microbiome’s interactions with
various aspects of host sociality, including sociability, social cognition, social stress, and autism. We discuss evidence of
microbial associations with the most likely physiological mediators of animal social interaction. These include the structure
and function of regions of the ‘social’ brain (the amygdala, the prefrontal cortex, and the hippocampus) and the regulation
of ‘social’ signalling molecules (glucocorticoids including corticosterone and cortisol, sex hormones including testosterone,
oestrogens, and progestogens, neuropeptide hormones such as oxytocin and arginine vasopressin, and monoamine neuro-
transmitters such as serotonin and dopamine). We also discuss microbiome-associated host genetic and epigenetic processes
relevant to social behaviour. We then review research on microbial interactions with olfaction in insects and mammals,
which contribute to social signalling and communication. Following these discussions, we examine evidence of microbial
associations with emotion and social behaviour in humans, focussing on psychobiotic studies, microbe–depression correla-
tions, early human development, autism, and issues of statistical power, replication, and causality.We analyse how the puta-
tive physiological mediators of the microbiome–sociality connection may be investigated, and discuss issues relating to the
interpretation of results. We also suggest that other candidate molecules should be studied, insofar as they exert effects on
social behaviour and are known to interact with the microbiome. Finally, we consider different models of the sequence of
microbial effects on host physiological development, and how these may contribute to host social behaviour.
Key words: host–microbe interactions, sociality, autism, emotion, social brain, neurotransmitters, steroids, olfaction, psy-
chobiotics, gene expression
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I. INTRODUCTION
All multicellular life hosts microbial life, and the relation-
ships between microorganisms and host lineages appear
to be stable over millions of years of host evolution
(Moeller et al., 2016, 2019; Nishida & Ochman, 2018,
2019). In animals, the majority of these microbes reside
in the intestinal tract, where they may number in the tril-
lions. In mammals, microbial colonisation of the host
begins during parturition, with the mother’s vaginal and
faecal microbes being transmitted to, and subsequently
becoming established within, the infant gut (Dominguez-
Bello et al., 2010; Mueller et al., 2015; Ferretti et al.,
2018; Sprockett, Fukami, & Relman, 2018). The infant
microbial community then undergoes substantial reorga-
nisation in response to changes in development, health,
and the environment (Koenig et al., 2011), but also con-
tinues to be shaped by microbial transmission from the
mother (Ferretti et al., 2018; Moeller et al., 2018). The
gut microbiome refers to the community of microbes,
microbial genes, and the environment they inhabit
(Marchesi & Ravel, 2015).
A surge of investigations on the gut microbiome during the
past two decades has revealed that these microbes make
important contributions to numerous aspects of animal
health and physiology across the lifespan (McFall-Ngai
et al., 2013; Kundu et al., 2017; Rook et al., 2017). In particu-
lar, gut microbes contribute to the regulation of host metab-
olism, adiposity, and energy balance (Bäckhed et al., 2004;
Turnbaugh et al., 2006; Nicholson et al., 2012), as well as
appetite and nutrient intake (Perry et al., 2016), and the mat-
uration and activity of the immune system (Fung, Olson, &
Hsiao, 2017). More recently, gut microbes have been found
to influence brain development and function (Diaz Heijtz
et al., 2011; Braniste et al., 2014; Sampson & Mazmanian,
2015; Sharon et al., 2016; Vuong et al., 2017).
Alongside these effects on the host’s peripheral and central
physiology, a growing body of evidence suggests that the
microbiome influences host psychological processes such as
emotion, learning, and memory (Diaz Heijtz et al., 2011;
Cryan & Dinan, 2012; Foster & McVey Neufeld, 2013;
Dinan et al., 2015; Vuong et al., 2017; Hoban et al., 2018; Sar-
kar et al., 2018). Several investigations in this area are begin-
ning to reveal associations between the microbiome and
animal sociality (Hsiao et al., 2013; Desbonnet et al., 2014;
Arentsen et al., 2015; Tung et al., 2015; Buffington et al.,
2016; Parashar & Udayabanu, 2016; Stilling et al., 2018),
and researchers have begun developing hypotheses on the
evolutionary and biological mechanisms underpinning
microbiome–sociality associations (Montiel-Castro et al.,
2013; Stilling et al., 2014; Archie & Tung, 2015; Münger
et al., 2018). For an in-depth analysis of these hypotheses in
terms of evolutionary theory, see Johnson & Foster (2018).
However, to date there is little evidence that elucidates
which causal physiological pathways (at the systems, cellular,
and molecular levels) mediate microbial contributions to host
social behaviour. Here, we describe three potentially relevant
mediators of the link between the microbiome and animal
sociality (see Fig. 1). First, the microbiome affects the devel-
opment and function of brain regions such as the amygdala,
hippocampus, and prefrontal cortex (Sudo et al., 2004;
Hoban et al., 2016; Luczynski et al., 2016) that are known to
contribute to social cognition and social behaviour. Second,
the microbiome is capable of generating or regulating the
bioavailability of a large number of signalling molecules that
influence animal social behaviour, including glucocorticoids,
sex hormones, neuropeptides, and monoamines (Sudo et al.,
2004; Wikoff et al., 2009; Markle et al., 2013; Poutahidis
et al., 2013). Finally, the microbiome affects gene expression
and epigenetic processes relevant to social behaviour.
Although these investigations themselves often do not explic-
itly link changes in the brain, biochemicals, and gene expres-
sion to social behaviour, they do indicate the possible
physiological pathways through which the microbiome may
influence sociality. Our goal, therefore, is to connect these
findings in the context of their relevance to animal social
behaviour in order to elucidate some of the physiological
mechanisms that may underpin the microbiome–sociality
association. Although we focus mainly on the gut micro-
biome in this review, it should be noted that there are numer-
ous microbiomes distributed across the host body, including
the mouth, nose, vagina, and skin, all of which make contri-
butions to host physiology (Dethlefsen, McFall-Ngai, & Rel-
man, 2007; Costello et al., 2009; Grice & Segre, 2011).
We first provide a brief overview of the experimental
methods used in this field, focussing on pharmacological
manipulations, microbial transfers, and germ-free models
(i.e. animals that are born and reared in sterile settings, and
are therefore devoid of anymicroorganisms). Then, we adopt
a top-down approach, beginning with an overview of exper-
imental investigations of the microbiome–sociality relation-
ship in animals. We synthesise laboratory evidence of the
microbiome’s role in the regulation of brain circuitry and sig-
nalling molecules implicated in social behaviour. We
describe microbial interactions with potential molecular
genetic mechanisms underlying animal social behaviour.
We consider the contributions of the microbiome to social
olfactory signalling in insects and mammals. We also assimi-
late the emerging research on microbial associations with
human emotion and social behaviour, and discuss issues of
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statistical power and replication. We then focus on the rela-
tionship between social behaviour and its underlying physiol-
ogy and how the microbiome may affect this relationship.
Specifically, although the microbiome influences numerous
physiological substrates of social behaviour, there is little evi-
dence for microbiome! host physiology! social behaviour
pathways. Finally, we describe the importance of attempting
to disentangle the order and nature of microbial effects on
sociality.
II. EXPERIMENTAL METHODS IN
MICROBIOME–HOST INTERACTION RESEARCH
Three of the most common laboratory experimental tech-
niques in investigating host–microbiome interactions are
the use of pharmacological or exogenous manipulations
(e.g. antibiotics, probiotics, and prebiotics), germ-free
models, and microbiome transplants (via faecal transfers).
As we and others have described these methods elsewhere
(Sarkar et al., 2018), we cover them only briefly here
(see Fig. 2).
(1) Exogenous manipulations
The microbial content of the gut can be exogenously manip-
ulated using antibiotics, probiotics, prebiotics, and psycho-
biotics (which are a subset of probiotics and prebiotics).
(a) Antibiotics
The effect of antibiotics on gut bacteria depends on the type
of antibiotic used and its mode of action. Since antibiotics
can and often do ablate non-target microbial populations,
they may exert a widespread and significant impact on the
host microbiome. Furthermore, not all antibiotic effects nec-
essarily occur via modulation of the microbiome (Forsythe,
Kunze, & Bienenstock, 2016). For instance, some antibiotic
molecules may exert physiological and psychological effects
by directly interacting with microglia, enteric neurons, or
by modulating enzymatic action (Forsythe et al., 2016). Since
antibiotic administration studies do not always assess changes
in microbial populations directly, it is possible that beh-
vioural outcomes occur via antibiotic effects on non-
microbial targets. Furthermore, even if researchers do
measure changes in the microbiome that covary with a par-
ticular behaviour, it does not rule out the possibility that
other, non-microbial changes in response to antibiotic expo-
sure may also have contributed to any observed behavioural
effects.
(b) Probiotics
Probiotics are exogenous live bacteria introduced into the
host gut via direct ingestion or oral gavage (the latter in the
case of animals). Bacteria from the Bifidobacterium and Lactoba-
cillus genera are often used as probiotics. Once ingested, these
microbes may then have opportunities to colonise the host
Fig. 1. Proposed physiological mediators of the microbiome–sociality relationship. We propose that the microbiome affects host
social behaviour via regulation of: (i) the structure and function of the social brain, (ii) signalling molecules known to be involved in
social behaviour, and (iii) host genetic and epigenetic processes. In addition to the arrows depicted in the diagram, the
microbiome’s effects on the structure of the social brain and its signalling molecules may, at least in part, be due to genetic and
epigenetic mechanisms.
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(perhaps only transiently) and may influence the host’s phys-
iology. However, the incoming probiotics face colonisation
resistance in the gut, both from resident microbes (Zmora
et al., 2018) and the chemical and physical environment of
the gut itself (e.g. low pH, rapid effluent flow, secretion of
bile, and antimicrobial peptides) (Walter & Ley, 2011). Fur-
ther research is needed to determine the proportion of
ingested probiotics that reach and colonise the gut, dose–
response associations, the longevity of probiotic effects, and
any possible long-term effects of probiotics on the micro-
biome (Sarkar et al., 2016).
(c) Prebiotics
Prebiotics are nutritive resources for microbes, such as indi-
gestible oligosaccharides, that are introduced into the gut to
support the growth of beneficial microorganisms. Bacterial
fermentation of prebiotics often results in the production of
short-chain fatty acids (SCFAs) which can exert a wide range
of physiological effects, including on the immune system and
metabolism, and the enteric and central nervous systems
(Kao, Harty, & Burnet, 2016; Kimura et al., 2011; Koh et al.,
2016). However, some prebiotics are able to exert physiolog-
ical effects independent of their effects on microbial popula-
tions (Forsythe et al., 2016). For instance, oligosaccharides
may bind directly to the immune system’s pattern-
recognition receptors in the lumen or physically prevent
these receptors from detecting microbes, with potential
anti-inflammatory effects (Bode et al., 2004; Eiwegger
et al., 2010).
(d) Psychobiotics
The collection of probiotics and prebiotics that exert psycho-
logical effects via the microbiome–gut–brain axis are defined
as ‘psychobiotics’ (Dinan, Stanton, & Cryan, 2013; Sarkar
et al., 2016), and researchers may also consider expanding
the definition of psychobiotics to include other substances
such as antibiotics or dietary components, if their psycholog-
ical consequences are at least partially mediated by the
microbiome (Sarkar et al., 2016). In particular, the micro-
biome is extremely sensitive to the host’s diet (Wu et al.,
2011; David et al., 2014a, 2014b; Carmody et al., 2015,
2019; Sonnenburg et al., 2016), with diet-induced changes
becoming detectable in the microbiome even a day later in
some instances (Wu et al., 2011; David et al., 2014a). As such,
we have suggested the possibility that diet could be the stron-
gest source of psychobiotics (Sarkar et al., 2018).
(2) Germ-free models
Germ-free animals are born and raised in microbe-free envi-
ronments, and are therefore important resources for under-
standing the influence of microbes on animal physiology.
However, it should be noted that germ-free animals differ
from conventional animals in terms of both their physiology
and social behaviour, and therefore when these animals are
colonised by bacteria (e.g. via probiotics or microbiome
transplants), the results cannot necessarily be extrapolated
to animals with normal microbiomes (Hanage, 2014). The
most attention is paid to the gut microbiome, which forms
the largest and most complex microbial community in the
body. The gut microbiome reaches densities in the large
intestine that exceed those of other body sites by several
orders of magnitude, and the composition of this distal gut
community can be inferred non-invasively through DNA
sequencing of faecal samples. However, there are also dis-
tinct microbial communities associated with other body sites
including the skin, mouth, lungs, vagina, and nose, and all of
these microbial communities presumably contribute to host
health and homeostasis. Germ-free animals lack all of these
microbiomes simultaneously and thus it cannot necessarily
Fig. 2. Experimental designs in animalmicrobiome research. (A)Themicrobial compositionof the gut canbemanipulatedwith antibiotics,
probiotics, and prebiotics. (B) Germ-free mice are raised in sterile environments and possess no intrinsic microbes. (C) Microbes can be
transferred from one animal to another, either via co-housing (i.e. sharing the same physical environment), or by transplantation of faecal
matter. The arrows show that germ-free mice can be colonised with specific types of probiotics (monoassociation), with normal or atypical
microbiomes from other conspecifics (via co-housing or faecal transplants), and with normal or atypical microbiomes from humans in
order to evaluate the extent to which the microbiome can recapitulate donor phenotypes in the recipient.
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be deduced that the differences observed in germ-free ani-
mals arise solely from the absence of the gut microbiome,
given that conventionally colonised animals have numerous
other microbiomes which may exert independent and inter-
active effects on host physiology.
(3) Microbial transfers
Gut microbes can be transmitted from one animal to another
via the transfer of faecal matter, which can occur when co-
housing animals (a process that is enhanced in coprophagic
species), or more directly by transplanting faecal content
from one animal to another.
(a) Co-housing
Merely housing animals in the same physical environment
enables a degree of microbial transfer among individuals.
The co-housing approach relies on the environmental and
social transmission of microbes among animals (Ridaura
et al., 2013). In some cases, microbes transferred via co-
housing can alter phenotypes in recipient mice, including
the induction of inflammation (Rehaume et al., 2014), as well
as affecting other aspects of host physiology. A recent study
showed that bacterial transfer via co-housing was sufficient
to induce immunological changes associated with neurode-
velopmental abnormalities in mice (Kim et al., 2017). Simi-
larly, microbiome-related social deficits have in some cases
been reversed by co-housing experimental and control mice
(Buffington et al., 2016). These results demonstrate the effi-
cacy of co-housing as a means of microbial transfer in mice,
and justify the use of co-housing to at least partially homoge-
nise microbiome composition in mouse experiments
(Laukens et al., 2016). However, microbial ‘homogenisation’
(or mixing of the microbiomes of co-housed animals) does
not consistently occur, and in some cases, microbes may only
be transmitted unidirectionally between animals. Specifi-
cally, an important study found that mice carrying an ‘obese’
microbiome were sensitive to colonisation by microbes from
co-housed mice carrying ‘lean’ microbiomes under specific
dietary conditions, but the opposite was not the case
(Ridaura et al., 2013).
(b) Transplantation of faecal microbes
A germ-free mouse can be administered a faecal transplant
from a healthymouse (conventionalisation). Researchers have
recently established that these donated faecal microbes can
survive in the recipient’s gut for at least 3 months (Li et al.,
2016). However, microbes from one donor do not always
coexist with the recipient’s microbiome to the same extent
in different recipients, suggesting that host factors (e.g. host
genetics, physiology, or the host’s microbiome itself) can influ-
ence the successful establishment of new microbes in the gut.
With appropriate controls, changes in host physiology and
social behaviour that follow a faecal transplant can be attrib-
uted to the effects of the donor’s microbiome. Germ-free and
normally colonised mice can also be colonised with disease-
associated microbiomes, either from conspecifics or from
humans. In these cases, the microbiome donor has a specific
condition (e.g. obesity, anxiety, depression, autism). If
microbes are sufficient to induce the physiological or beha-
vioural features of the condition, then faecal transplants to
rodents should result in a recapitulation of condition-relevant
phenotypes in the recipients, assuming that the faecal micro-
biome accurately captures the total gut microbiome. While
there is evidence that this is the case (Eckburg et al., 2005),
recent research does suggest that the microbiome associated
with the gut mucosa may have limited representation in stool
samples (Zmora et al., 2018).
Overall, however, faecal transplants allow the inference
that the microbiome makes at least some causal contribution
to the condition of interest. It is important to keep in mind
that these experiments do not necessarily reveal the mecha-
nisms underlying microbial contributions to the condition,
or which microbes are involved.
III. MICROBIAL ASSOCIATIONS WITH SOCIAL
STRESS AND SOCIAL BEHAVIOUR
We first focus on the association between microbes and host
sociality, with an emphasis on social stress and social behav-
iour (see Fig. 3). We also consider autism, the key features
of which include impairments in normal social behaviour.
We focus on rodent studies, as most experimental research
on microbiome–sociality relationships uses rodents as exper-
imental models (although some studies also examine fish and
insects). We illustrate the diversity, potential, and limitations
of investigations of the microbiome–sociality relationship.
Despite the opportunities that rodent models provide for dis-
covering effects of the microbiome on host behavioural phe-
notypes, it is important to keep in mind that such findings
may not necessarily be extrapolated to humans.
(1) Social stress in rodents
Stress and negative emotional states significantly alter social
interactions, and form a core component of mood disorders
and many other psychiatric conditions. In mice, the stress
induced by social aggression and subordination to dominant
conspecifics triggers changes in the gut microbiome and
immune function (Bailey et al., 2011; Galley et al., 2014; Bhar-
wani et al., 2016). Social disruption and social defeat
(in which mice are forced to interact with aggressive conspe-
cifics) can reduce gut bacterial diversity (Galley et al., 2014;
Bharwani et al., 2016; Szyszkowicz et al., 2017), and can also
alter the abundance of specific bacterial taxa. These changes
include, for instance, decreases in the relative abundance of
the Bacteroides and Lactobacillus genera (Bailey et al., 2011; Gal-
ley et al., 2014) and increases in the relative abundance of the
Clostridium genus (Bailey et al., 2011). Moreover, some of these
changes in bacterial populations occur as early as within
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2 hours of exposure to the social stressor (Galley et al., 2014),
and can last for at least 3 weeks (Szyszkowicz et al., 2017), sug-
gesting that microbial responses to the social environment
may be both rapid and long-lasting. These microbial changes
may occur in parallel with elevations in peripheral proin-
flammatory cytokines such as interleukin-6 (Bailey et al.,
2011; Bharwani et al., 2016), although this is not always the
case (Szyszkowicz et al., 2017). Antibiotics have also been
observed to attenuate stress-induced proinflammatory
immunological activity, further suggesting that gut microbes
may mediate the relationship between social stress and
inflammation (Bailey et al., 2011).
Social stress can also be induced by isolation (Weiss et al.,
2004). Postweaning separation of rats from conspecifics led
to elevations in the Actinobacteria phylum, reductions in
the Clostridia class, and an unexpected decrease in hippo-
campal interleukin-6 (Dunphy-Doherty et al., 2018). Insofar
as maternal contact during infancy is a crucial form of
early social interaction (Feldman, 2017), maternal separa-
tion may also be interpreted as a form of social isolation,
and is frequently used as a method of inducing stress in
young rodents (Meaney et al., 1996; Desbonnet et al.,
2010). In this regard, maternal separation of rat pups
affects gut bacterial composition, reducing the relative
abundance of the Lactobacillus genus, and elevating concen-
trations of proinflammatory cytokines (Gareau et al., 2007;
O’Mahony et al., 2009).
While social stress does appear to reliably alter micro-
bial composition, it also seems that different forms of
social stress – defeat and aggression (Bailey et al., 2011;
Galley et al., 2014; Bharwani et al., 2016), and isolation
and separation (Gareau et al., 2007; O’Mahony et al.,
2009; Dunphy-Doherty et al., 2018) – trigger different
types of changes, with inconsistencies across studies. Aside
from the nature of the stressor, other factors that likely
contribute to differing effects of social stress on microbial
composition include the species, strain, and sex of the
rodent, as well as the age at which the stressor is experi-
enced (infancy in the case of maternal separation, adult-
hood in the case of social defeat and disruption).
Given the bidirectional communication between the gut
microbiome and brain, it is possible that the animal’s micro-
biome can itself affect the stress response. For example, a
recent study found that mice which were more resilient to
social stress also had a higher prevalence of Bifidobacterium in
the gut compared to susceptible individuals, suggesting that
gut bacteria may buffer against stress (Yang et al., 2017). Sim-
ilarly, social avoidance induced by social stress was found to be
most extreme in mice with lower levels of Gram-positive Fir-
micutes bacteria (Oscillospira spp. and Turicibacter spp.) and
higher levels of Gram-negative Bacteroidetes (Flavobacterium
spp., Parapedobacter spp., and Porphyromonas spp.) (Szyszkowicz
et al., 2017). While these findings are of course correlational,
they are at least suggestive of the possibility that certain bacte-
ria may promote psychological resilience against social stress,
and as such these potential protective effects warrant further
investigation.
(2) Social behaviour in rodents
A widely used measure of rodent social behaviour is the
three-chamber test (see Fig. 3), which provides an index
of rodent sociability and social cognition (Nadler et al.,
2004; Moy et al., 2007; Silverman et al., 2010; Yang, Sil-
verman, & Crawley, 2011). The task involves two steps,
following an initial habituation phase. First, the rodent
is placed in the middle of three interconnected chambers.
One of the adjacent chambers contains an unfamiliar
conspecific, while the other contains a novel object (alter-
natively, this chamber may be empty). Normal rodent
sociability is indexed by greater behavioural preference
for the conspecific. The second step also involves three
interconnected chambers. In this case, the adjacent
chambers contain a familiar rodent (from the first step)
and an unfamiliar rodent. Typical social cognition is
indexed by greater behavioural preference for the unfa-
miliar conspecific. Disturbances in sociability and social
cognition are reflected in reduced interest in the conspe-
cific (step 1) and the unfamiliar conspecific (step 2),
respectively.
This three-chamber test is frequently used to assess
social behaviour in germ-free rodents in microbiome
experiments. For instance, unlike their normally colo-
nised counterparts, germ-free mice exhibit social impair-
ments in the three-chamber test. In particular, they do
not show the normal preference for interacting with
other rodents (impaired sociability), nor a preference
for interacting with an unfamiliar mouse over a familiar
one (impaired social cognition) (Desbonnet et al., 2014;
Buffington et al., 2016; Stilling et al., 2018). Microbial
reconstitution attenuated the impairments in sociability,
but did not ameliorate social cognition (Desbonnet
et al., 2014; Stilling et al., 2018), suggesting that some –
but not all – of the social deficits may be reversible.
However, because both sociability and social cognition
were each only tested once in these studies, it may also
be the case that changes in social cognition occur more
slowly than changes in sociability, and may therefore
be apparent only in further testing sessions. Similar to
germ-free mice, germ-free rats also show impairments
in sociability in the early stages of a social interaction
task (Crumeyrolle-Arias et al., 2014). Overall, these
results provide causal evidence that some aspects of nor-
mal host sociality may require the presence of a
microbiome.
However, there is one intriguing report that germ-free sta-
tus increased sociability in mice, as observed in the three-
chamber test (Arentsen et al., 2015). The mice used in this
study were older than those used in some of the research that
found that germ-free status decreased sociability (Desbonnet
et al., 2014; Stilling et al., 2018), and this may account for the
divergent effects of germ-free status on sociability. The
hypothesis that an animal’s age may affect how its micro-
biome influences its social behaviour could be tested by sys-
tematically examining social interactions in germ-free mice
of different ages.
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(3) The rodent gut microbiome and autism
(a) Associations with the gut microbiome in rodent models of autism
The microbiome has been implicated in autism, which is a
complex condition defined by deficits in social communication
and interaction, as well as rigid and repetitive behavioural pat-
terns (Baron-Cohen & Belmonte, 2005; Happé, Ronald, &
Plomin, 2006). Autism is often also associated with gastrointes-
tinal and immunological disturbances (Horvath & Perman,
2002; Ashwood et al., 2011; Patterson, 2011; Onore, Car-
eaga, & Ashwood, 2012; McElhanon et al., 2014). Gastrointes-
tinal and immunological processes are in turn associated with
the microbiome, and as such, the nature of microbial
involvement in the multidirectional relationships between the
gastrointestinal system and the immune system in autism are
unclear, and are an important area of investigation (Azhari,
Azizan, & Esposito, 2019).
A rapidly growing body of research is beginning to suggest
ways in which the microbiome may be functionally involved
in autism (Vuong et al., 2017; Vuong & Hsiao, 2017), raising
the possibility that the microbiome may contribute to its
aetiology. For instance, research in rodents shows that mater-
nal experiences can disturb microbial composition in the off-
spring. These maternal experiences include exposure to
antibiotics (Degroote et al., 2016), acute systemic inflamma-
tion (i.e. maternal immune activation; Hsiao et al., 2013;
Fig. 3. Microbial associations with rodent social behaviour. A range of studies shows that rodent social behaviour is influenced by the
microbiome. (A, B) Microbial profiles rapidly shift in response to the social environment, including social defeat stress and social
isolation, providing evidence of how the social environment affects the microbiome via the hypothalamic–pituitary–adrenal (HPA)
axis. (C) Rodent sociability and social cognition can be influenced by manipulation of the microbiome. In the three-chamber test
shown here, the mouse is sequentially exposed to two conditions after habituation (first row). This test measures preferences for
social interaction and social novelty. Preference for social interaction is indexed by choosing to interact with a novel conspecific
over a novel object (second row). Preference for social novelty is indexed by choosing to interact with a novel mouse over the
familiar mouse from the previous phase (third row). Some of the social deficits can be mitigated with probiotic treatment.
(D) Disrupting the microbiome can trigger rigid behavioural patterns that are thought to reflect autistic phenotypes such as
repetitive behaviour (indexed by marble-burying tendencies), which can be mitigated with probiotic treatment.
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Kim et al., 2017; Lammert et al., 2018; Morais et al., 2018), or
consumption of high-fat diets (Buffington et al., 2016), all of
which alter the offspring’s microbiome. Crucially, these
microbial perturbations are associated with behavioural pro-
files consistent with autistic traits, including reduced sociabil-
ity and repetitive behaviour [assessed, for example, by
excessive burying of marbles (Thomas et al., 2009; Malkova
et al., 2012)].
In particular, a recent study (Buffington et al., 2016) found
that pregnant mice that consumed high-fat diets gave birth to
offspring that showed autistic-like phenotypes. When healthy
mice engaged in regular social interactions, long-term poten-
tiation occurred in the ventral tegmental area. In compari-
son, the autistic-type mice showed comparatively lower
levels of long-term potentiation in the ventral tegmental area
after social interactions, and also had fewer oxytocin-
expressing neurons. The causal role of the microbiome was
revealed using faecal transplants to transfer microbes from
the autistic-type mice to the control mice: the recipients
developed social behavioural deficits and showed impaired
long-term potentiation in the ventral tegmental area, as well
as reductions in oxytocin-expressing neurons. This suggests
that the microbiome is able to induce autistic-like phenotypes
in neurotypical recipients.
Perhaps most striking, however, is the finding that probi-
otic treatment with Lactobacillus reuteri and Bacteroides fragilis
ameliorated some of the autistic-like phenotypes in mice
(Hsiao et al., 2013; Buffington et al., 2016). While of course
still very far from clinical application to humans, such
rodent findings nonetheless provide early evidence that
some of the behavioural features of complex neurodevelop-
mental conditions may be at least partially reversible in
some cases through exogenous manipulation of the gut
microbiome.
The specific pathways through which the microbiomemay
contribute to autistic-like behaviours are still largely
unknown and in need of rigorous mechanistic elucidation.
However, recent efforts using the maternal immune activa-
tion model of autism in rodents have begun to uncover
microbiome–immune associations that affect the likelihood
of developing autistic phenotypes in response to inflamma-
tion during pregnancy. In mice, elevations in maternal con-
centrations of the proinflammatory cytokine interleukin-17a
produced by T helper 17 (TH17) cells may mediate the rela-
tionship between maternal infection during pregnancy and
infant autistic phenotypes (Choi et al., 2016). Signalling by
TH17 cells and interleukin-17a during pregnancy appears
to rely on the presence of segmented filamentous bacteria
in the maternal gut (Kim et al., 2017). Maternal immune acti-
vation in the absence of TH17-promoting segmented fila-
mentous bacteria in the gut does not produce autistic-type
offspring (Kim et al., 2017). However, when mice that were
lacking segmented filamentous bacteria were then exposed
to these bacteria, either directly or through interactions with
other mice carrying these bacteria, maternal immune activa-
tion did trigger autistic phenotypes in the offspring via eleva-
tions of interleukin-17a (Kim et al., 2017; Lammert et al.,
2018). These results suggest that maternal microbes may be
acting as environmental risk factors for autism.
The genetic background of the host may also moderate the
effects of environmental risk factors on the development of
autism. Host genes are known to exert some influence on
the composition of the microbiome (Goodrich et al., 2014),
and therefore host genetic factors may also influence the
microbiome–autism association. For instance, in a compari-
son of the effects of maternal immune activation on autistic
traits between C57BL/6J mice and NIH Swiss mice, the lat-
ter were found to bury significantly more marbles than the
former, although sociability was similarly impaired in both
strains following the intervention (Morais et al., 2018).
Genetic research on autism in humans has implicated
SHANK family genes in the aetiology of autism (Jiang &
Ehlers, 2013). SHANK genes (SHANK1, SHANK2, and
SHANK3) encode synaptic folding proteins, and genetic
manipulations that alter the expression of these proteins have
been used to model the effects of genetic risk factors of autism
(Jiang & Ehlers, 2013). A recent gene-knockout study found
that mice lacking Shank3 displayed autistic-like phenotypes
(e.g. impaired sociability and repetitive behaviours) alongside
several changes in gut bacterial composition and reductions
in the expression of γ-aminobutyric acid (GABA) receptors
in the hippocampus and prefrontal cortex (Tabouy et al.,
2018). Crucially, treatment with the probiotic Lactobacillus
reuteri attenuated the behavioural deficits and also increased
expression of GABA receptors in the affected brain regions
(Tabouy et al., 2018). Therefore, Lactobacillus reuteri appears
to diminish autism-related phenotypes in two distinct murine
models of autism (Buffington et al., 2016; Tabouy et al., 2018).
Indeed, researchers have now followed this lead to show
explicitly that Lactobacillus reuteri appears to be effective in
treating murine autism symptoms with diverse aetiologies
(Sgritta et al., 2019). These include environmental models
(maternal exposure to valproic acid), genetic models (Shank3
knockout), and idiopathic models (BTBR mice show autistic
traits but there are no known genetic or environmental
sources, and as such these mice are considered to represent
idiopathic autism). In all cases, treatment with Lactobacillus
reuteri ameliorated the social deficits associated with these
conditions (i.e. increased time in social interactions,
increased sociability, and increased preference for social nov-
elty compared to untreated mice). Vagotomy (i.e. surgical
removal of the vagus nerve) abolished probiotic benefits, sug-
gesting that the behavioural benefits of Lactobacillus reuteri are
mediated by the vagus nerve. Moreover, monoassociation of
germ-free mice with Lactobacillus reuteri also rescued social
functioning (Sgritta et al., 2019). These results suggest that
this probiotic can exert its effects independent of other
microbes and that it can rescue social impairments in diverse
mouse models of autism.
Another recent study sought to examine the effects of
transplanting gut microbes from autistic humans to mice
(Sharon et al., 2019). Germ-free mice were colonised using
faecal transplants from neurotypical or autistic donors, with
the autistic donors for this study comprising 11 individuals
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with mild, moderate, and severe autism. This initial genera-
tion of colonised mice was then used to breed a second gener-
ation. In particular, each member of the second generation
was bred from parents which had received microbiome trans-
plants from the same human donor. The gnotobiotic condi-
tions meant that vertical transmission of microbes could only
include microbial populations derived from human donors,
as those were the onlymicrobes that had colonised the parents.
This allowed for an examination of the causal contributions of
the microbiome to autism in the offspring.
The researchers did not observe any differences between
the mice carrying microbiomes derived from autistic donors
compared to mice carrying microbiomes derived from neu-
rotypical donors in the three-chamber test. However, the
experimental mice did show reduced social engagement with
conspecifics in a separate test investigating direct social inter-
actions, and also buried significantly more marbles com-
pared to the control group (although in this latter case, the
effect was only apparent when excluding mice whose micro-
biomes were derived from donors diagnosed with mild
autism). However, subsequent work by independent
researchers suggested that there may have been software-
associated technical issues in the original analysis that led to
errors in the estimates of statistical significance in the results.
In particular, researchers have suggested that the mouse data
may have been analysed as if each mouse received microbes
from independent donors, whereas in fact all of the mice
were colonised by microbes from one of 11 donors (meaning
that multiple mice received transfers from the same donor). It
appears that correcting for this issue leads to a loss of statisti-
cal significance in the case of social interaction, although the
differences in marble burying remained statistically signifi-
cant. Overall, therefore, it will be crucial to replicate these
results using a wider pool of autistic and neurotypical donors.
(b) Drawbacks to rodent models of autism and potential alternatives
In general, there is much debate over the utility of rodent
models of autism, and there is as yet no universally accepted
rodent model that is considered equivalent to the beha-
vioural impairments associated with autism in humans.
While of course atypical sociality and repetitive behaviour
in mice provide an attractive resemblance to human autism,
it is far from clear whether these behavioural impairments in
rodent models are effective at genuinely capturing the vastly
more complex phenotypes of human autism. Thus, while the
results of microbiome–sociality studies in rodents are cer-
tainly provocative and conceptually interesting, the distance
between rodent ‘autism’ and human autism poses a signifi-
cant translational barrier. Initiating human clinical trials on
the basis of only rodent results would be extremely resource
intensive and may not yield any meaningful results, and,
moreover, may unnecessarily subject young participants to
discomfort or distress associated with the testing procedures.
One solution that we have suggested previously is the use of
primate models after preclinical rodent results have been
established (Sarkar et al., 2018). In this regard, researchers
have recently developed a macaque (Macaca fascicularis)
model of autism with SHANK3 mutations using the
CRISPR–Cas9 (clustered regularly interspaced short palin-
dromic repeats–CRISPR-associated protein 9) gene-editing
system (Zhou et al., 2019). Crucially, alongside disturbances
in neurocircuitry, the macaques showed social impairments
and repetitive behaviour reminiscent of the hallmark features
of autism. As such, it may be worthwhile to consider, where
feasible, how microbial interventions affect autism-relevant
phenotypes in macaques prior to initiating human investiga-
tions. Though such primate studies would themselves be
highly resource intensive, in the long run they would likely
be more efficient if conducted as follow-ups to rodent studies
and prior to human studies.
IV. MICROBIAL INFLUENCES ON THE SOCIAL
BRAIN
Gut microbes make important contributions to brain
development and function (see Fig. 4), including the amyg-
dala and the prefrontal cortex, both of which are crucial
nodes in the network comprising the ‘social’ brain. In addi-
tion, the microbiome has been found to affect the hippo-
campus, which also plays a role in social cognition. The
microbiome also influences the hypothalamus, which regu-
lates a range of signalling molecules that exert well-known
social effects.
(1) Amygdala
The amygdala is a subcortical brain structure that plays an
important role in processing social-affective information
(Phelps & LeDoux, 2005), and mediates the experience of
stress, fear, and anxiety (Roozendaal, McEwen, & Chattarji,
2009). On the other hand, reduced amygdalar activity dur-
ing social perception tasks is hypothesised to be associated
with autism and autistic-type traits in humans (Baron-Cohen
et al., 1999, 2000). More recently, researchers have also
observed ‘simulation’ neurons in the primate amygdala
(Grabenhorst et al., 2019). Specifically, these neurons appear
to facilitate the simulation of the mental states of a monkey’s
social partners (Grabenhorst et al., 2019).
Several studies have revealed that the microbiome exerts
effects on the structure and function of the amygdala
(Cowan et al., 2018). For example, in germ-free mice, the lat-
eral amygdala, the basolateral amygdala, and the central
nucleus of the amygdala have a greater volume compared
to normally colonised controls (Luczynski et al., 2016). Den-
dritic hypertrophy has also been observed in the basolateral
amygdala of germ-free mice. In particular, the dendrites of
aspiny interneurons of germ-free mice were both longer
and had a greater number of branch points compared to nor-
mally colonised controls (Luczynski et al., 2016). The den-
drites of pyramidal neurons in the basolateral amygdala of
germ-free mice were also longer, with increased density of
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thin spines, stubby spines, and mushroom spines (Luczynski
et al., 2016). In mice, ingestion of the probiotic Lactobacillus
rhamnosus lowers amygdalar expression of GABAAα2 messen-
ger ribonucleic acid (mRNA) (Bravo et al., 2011). The micro-
biome also affects other aspects of gene expression in the
murine amygdala, which we discuss later (see Section VI).
There is also some evidence of a possible link between the
gut microbiome and the human amygdala, although it is far
less robust than findings in rodents. In particular, higher
levels of intrinsic Prevotella spp. in healthy volunteers were
associated with greater white matter connectivity between
the amygdala and the caudate (Tillisch et al., 2017). Higher
levels of Actinobacteria were also found to be positively cor-
related with fractional anisotropy of the amygdala (with
higher fractional anisotropy in turn predicting better micro-
structural organisation) (Fernandez-Real et al., 2015).
Researchers have also found preliminary evidence of an asso-
ciation between microbial diversity and the functional con-
nectivity between the amygdala and the thalamus (Gao
et al., 2019). However, it is important to note that since these
are correlational studies, it may be that the relationship
between the microbiome and the amygdala is mediated by
stress, since stress can affect both the amygdala and micro-
biome composition.
Two reward-related networks, the amygdala–nucleus
accumbens circuit and the amygdala–anterior insula circuit,
have also recently been shown to be associated with micro-
bially generated indole metabolites in humans (Osadchiy
et al., 2018). In particular, the concentrations of different
indole metabolites (indole, indoleacetic acid, and skatole)
obtained from faecal samples were positively correlated with
both anatomical and functional connectivity in the amyg-
dala (Osadchiy et al., 2018). Moreover, consumption of pro-
biotics (relative to controls) has been found to reduce activity
in a brain network implicated in processing emotional infor-
mation, including the amygdala, in a group of healthy
female volunteers (Tillisch et al., 2013). Notably, studies have
also failed to detect correlations between bacterial profiles
and amygdalar volume in comparisons of healthy individ-
uals and those diagnosed with irritable bowel syndrome
(Labus et al., 2017; Tillisch et al., 2017). As such, the strength
of the association between the microbiome and the amyg-
dala remains to be clarified. More generally, though intrigu-
ing, these reports will need to be followed up with larger
investigations in order to determine the nature of the
microbiome–amygdala relationship with greater specificity
and to test replicability.
(2) Prefrontal cortex
The prefrontal cortex is involved in high-level cognition and
executive functions (Miller & Cohen, 2001), and also makes
key contributions to social cognition, including impression
formation (Mitchell, Macrae, & Banaji, 2005), learning social
value (Behrens et al., 2008), and social and moral reasoning
(Anderson et al., 1999). Furthermore, in humans, the prefron-
tal cortex is associated with social network size both volumet-
rically (Lewis et al., 2011) and functionally (Noonan et al.,
2014, 2018), relationships that appear to be evident in other
primates as well (Sallet et al., 2011).
Fig. 4. Microbial influences on the social brain. The gut microbiome exerts a range of effects on the development and function of the
social brain. These include hippocampal neurogenesis, volumetric and morphological alterations in the amygdala and hippocampus,
prefrontal myelination, and hypothalamic oxytocin expression, as well as the development of both the hypothalamic–pituitary–
adrenal axis and hypothalamic–pituitary–gonadal axis. BDNF, brain-derived neurotrophic factor; miRNA, microRNA.
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Germ-free status in mice triggers morphological abnor-
malities in the prefrontal cortex, particularly enhanced thick-
ness of the myelin sheath and an upregulation of genes
associated with myelination and myelin plasticity (Hoban
et al., 2016). Microbial transfers from stressed mice have also
been found to trigger prefrontal demyelination and social
avoidance in healthy recipients (Gacias et al., 2016), suggest-
ing that the effects of stress on the brain may be at least par-
tially mediated by the gut microbiome. Furthermore, given
that social isolation in mice impairs adult prefrontal myelina-
tion (Liu et al., 2012) and that social isolation itself affects the
microbiome (Gacias et al., 2016; Hoban et al., 2016), it is rea-
sonable to hypothesise that some of the effects of social isola-
tion on myelination of the prefrontal cortex may be
microbially mediated. There is also evidence that the pre-
frontal cortex is sensitive to probiotics. In particular, mice
that were treated with the probiotic Lactobacillus rhamnosus
showed reduced expression of GABAAα2 mRNA in the pre-
frontal cortex (Bravo et al., 2011).
(3) Hippocampus
The hippocampus plays an essential role in the generation
and maintenance of cognitive spatial maps (O’Keefe & Dos-
trovsky, 1971). Although often not considered within the typ-
ical network comprising the social brain, it is becoming
increasingly apparent that the hippocampus plays an impor-
tant role in mammalian social cognition. For example, the
hippocampus contributes to social recognition and social
memory (Kogan, Franklandand, & Silva, 2000). Analogous
to its role in navigating physical space, researchers have also
recently uncovered hippocampal contributions to navigating
‘social’ space in humans (Tavares et al., 2015). In particular,
the hippocampus tracks others in this social space based on
their degree of affiliation or closeness to the self and the social
status they possess (Taveras et al., 2015). Importantly, hippo-
campal abnormalities, including cellular changes and volu-
metric reduction, have also been linked to depression
(MacQueen et al., 2003; Hastings et al., 2004; Stockmeier
et al., 2004; Videbech & Ravnkilde, 2004; Rosso et al.,
2005). As such, it is worth considering the possibility that
some of the relationships between the microbiome and
depression could be mediated by changes in hippocampal
structure and function.
The effects of the microbiome on the rodent hippocampus
are some of the most consistent in the microbiome–gut–brain
field. For example, germ-free mice show reduced levels of
hippocampal brain-derived neurotrophic factor (BDNF)
and BDNF mRNA (Clarke et al., 2013; Diaz Heijtz et al.,
2011; Sudo et al., 2004), a protein involved in neuroplasticity
andmemory (Greenberg et al., 2009). Furthermore, both pre-
biotics and probiotics increase hippocampal BDNF levels
(Desbonnet et al., 2008; Savignac et al., 2013; Burokas
et al., 2017).
Relative to normally colonised controls, germ-free status
in mice impacts several aspects of dendritic morphology in
the hippocampus (as well as the amygdala), including
reduced dendritic length and a smaller number of branch
points (Luczynski et al., 2016). Overall hippocampal dendritic
spine density is also lower in germ-free mice, a reduction
accounted for by reduced densities of stubby spines and
mushroom spines (Luczynski et al., 2016). At the same time,
germ-free mice also show greater total volume of certain hip-
pocampal regions, such as CA2/3 (Luczynski et al., 2016).
Evidence is also emerging that the microbiome regulates
adult neurogenesis in the hippocampus (Möhle et al., 2016;
Ogbonnaya et al., 2015). In particular, germ-free status in
mice elevates hippocampal neuroproliferation that is not
reversible by colonisation with a normal microbiome
(Ogbonnaya et al., 2015). However, antibiotic exposure in
adult mice supresses hippocampal neurogenesis, but this
can be reversed via treatment with probiotics (Möhle
et al., 2016).
There is much less evidence of a hippocampal association
with the microbiome in humans, but subgroup analysis from
one small study suggests that individuals with high levels of
Prevotella spp. may have lower hippocampal volume, and also
show reduced hippocampal activity in response to negative
emotional images (Tillisch et al., 2017). Since activity in the
hippocampus has been associated with emotional regulation
(Phelps, 2004), reduced Prevotella-associated hippocampal
activation in response to negative emotional stimuli may
be a risk factor for certain psychiatric conditions (Tillisch
et al., 2017), although of course such an interpretation is
highly speculative (the result itself should be subject to repli-
cation, and the causal contribution of Prevotella should be
assessed).
V. MICROBIAL REGULATION OF SOCIAL
SIGNALLING MOLECULES
In addition to modulating brain anatomy and physiology, the
microbiomemay also affect the central nervous system via the
generation and regulation of a range of ‘social’ signalling
molecules including glucocorticoids, sex steroids, neuropep-
tides, and monoamines (see Fig. 5). Microbial communities
regulate the biosynthesis and bioavailability of several neuro-
transmitters that play important roles in animal social inter-
action. There has also been a steadily growing interest in
microbial endocrinology in terms of the relationship between
microbes and host neuroendocrine function (Lyte, 2014), and
such microbe–hormone interactions could be relevant to
social behaviour. For instance, the microbiome affects sev-
eral steroids regulated by the hypothalamus, including along
the hypothalamic–pituitary–adrenal (HPA) axis and
hypothalamic–pituitary–gonadal (HPG) axis.
There are at least three non-mutually exclusive path-
ways by which microbes regulate the biosynthesis and bio-
availability of these signalling molecules. First, these
molecules may be generated as by-products of bacterial
metabolism. For instance, Lactobacillus and Bifidobacterium
secrete GABA, Lactobacillus secretes acetylcholine,
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Escherichia and Bacillus secrete norepinephrine, and Bacillus
and Serratia secrete dopamine (Lyte, 2011). Second, bacte-
rial metabolites such as SCFAs and secondary bile acids
can interact with host cells that regulate the production
of signalling molecules. Third, signalling molecules can
be converted into their active forms via bacterially medi-
ated enzymatic deconjugation. In the examples that fol-
low, we describe instances of all three processes.
These signalling molecules also vary in their brain-
penetrant properties, with some readily able to cross the
blood–brain barrier (e.g. glucocorticoids and sex steroids),
while others are thought to be unable to do so
(e.g. oxytocin). Overall, these molecules may exert their
behavioural effects by entering the brain directly (if the
molecule or its precursor can cross the blood–brain bar-
rier), via effects on the immune system, or by modulating
activity of the vagus nerve (Johnson & Foster, 2018). They
may also perhaps exert their behavioural effects by modu-
lating the activity of the proximal synapses of the enteric
nervous system that innervates the gut, changes that may
then be relayed to the brain (Sarkar et al., 2016; Johnson &
Foster, 2018).
(1) Glucocorticoids
The gut microbiome influences concentrations of endoge-
nous steroids, including glucocorticoids such as cortisol
and corticosterone, which are the hormonal end-products
of the HPA axis. The primary physiological function of
glucocorticoids is glucose metabolism, a process that pre-
pares the body for action by releasing energy. Impor-
tantly, once glucocorticoids are released into systemic
circulation, they are also able to cross the blood–brain
barrier, and can therefore interact directly with the central
nervous system (Pardridge & Mietus, 1979). At the psy-
chological level, glucocorticoid release is tightly coupled
with the experience of fear and anxiety (Dickerson &
Kemeny, 2004). The elevatation of glucocorticoids is con-
sidered to be one of the physiological hallmarks of stress.
Hyperactivity of the HPA axis in humans predicts behav-
iours such as social avoidance (Roelofs et al., 2009), which
have implications for social interaction. Similarly, pharma-
cologically elevating corticotropin-releasing factor in
rodents enhances anxiety and supresses normal social
interaction (Dunn & File, 1987).
The effect of the microbiome on the development of the
HPA axis, and therefore its influence on the host’s stress
response, has become an important area of investigation
(de Weerth, 2017). For instance, germ-free rodents consis-
tently show elevated corticosterone levels in response to stress
compared with normally colonised animals (Sudo et al., 2004;
Neufeld et al., 2011; Crumeyrolle-Arias et al., 2014). Ingestion
of probiotics and prebiotics has been noted to reduce levels of
circulating glucocorticoids in both humans and rodents, and
is also associated with decreased anxiety (Bravo et al., 2011;
Messaoudi et al., 2011; Schmidt et al., 2015; Allen et al.,
2016; Burokas et al., 2017).
(2) Sex steroids
Gut microbes are also associated with the activity of host sex
steroids such as androgens, oestrogens, and progestogens,
the hormonal end-products of the HPG axis. Like glucocorti-
coids, sex steroids are capable of crossing the blood–brain
barrier and can therefore bind directly to neurons in the brain
(Pardridge & Mietus, 1979). It has been known for several
decades that the microbiome regulates the bioavailability of
endogenous steroids, as early studies found that germ-free rats
produced very small quantities of steroids compared to nor-
mally colonised rats (Eriksson, Gustafsson, & Sjövall, 1969).
Germ-free status was also found to interfere with normal
reproduction in both males and females, and these effects
were reversed by microbial colonisation (Shimizu et al.,
1998). Technological advances have resulted in more fine-
grained studies, and many of the microbial effects on these
molecules have been investigated within the last decade.
(a) Androgens
Androgens are a major class of steroids that regulate male
sexual development, exerting a variety of important physio-
logical and psychological effects. They are also present in
much smaller quantities in females, but their role in female
biology and behaviour is generally less well understood com-
pared to males. The primary androgen is testosterone, an
end-product of the HPG axis. Others include androstenedi-
one, dehydroepiandrosterone, and dihydrotestosterone. In
males, rising testosterone levels associated with adolescence
trigger sexual development, spermatogenesis, and the devel-
opment of secondary sexual characteristics (Mooradian,
Morley, & Korenman, 1987; Hau, 2007; Walker, 2011,
2009). From the perspective of animal sociality, testosterone
controls mating and reproductive behaviour, especially in
males, and is implicated in the motivation for status-seeking,
including in humans (Mazur, 1985; Mazur & Booth, 1998;
Archer, 2006; Eisenegger, Haushofer, & Fehr, 2011).
Male germ-free mice show markedly lower serum testos-
terone concentrations compared to normally colonised male
conspecifics, while female germ-free mice show the opposite
pattern (Markle et al., 2013). The transplantation of microbes
from adult males into pre-adolescent female recipients (via
faecal transfer) increases testosterone concentrations in the
recipients (Markle et al., 2013). Similarly, researchers have
found that germ-free status is associated with lower levels of
both circulating gonadotropins and intratesticular testoster-
one concentrations, as well as reduced integrity of the
blood–testis barrier, which protects the gonads from many
peripheral influences such as proinflammatory factors (Al-
Asmakh et al., 2014). The impairment in blood-testis barrier
integrity in germ-free mice was associated with reduced
expression of cell adhesion proteins, while colonisation with
Clostridium tyrobutyricum ameliorated the expression of cell
adhesion proteins and restored the integrity of the blood–
testis barrier (Al-Asmakh et al., 2014). Furthermore, ageing
mice fed Lactobacillus reuteri show higher concentrations of
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serum testosterone and enhanced rates of spermatogenesis
(Poutahidis et al., 2014). Moreover, relative to controls,
mice treated with Lactobacillus reuteri display both morpho-
logical changes (as measured by greater testis size) and cel-
lular changes (as measured by a proliferation of
testosterone-producing Leydig cells) (Poutahidis et al.,
2014). Together, these findings point to a causal role of
the gut microbiome in the biosynthesis or regulation of
testosterone and testicular morphology and function across
the lifespan, suggesting that the microbiome may therefore
influence some aspects of reproduction and reproductive
behaviour.
(b) Oestrogens
The microbiome also influences endogenous concentrations
of oestrogens, which are an important group of ‘female’
reproductive steroids (they are also present in smaller quanti-
ties in males). They include oestradiol (the primary oestro-
gen), oestrone, and oestriol. Oestrogens regulate the
maturation and maintenance of the female reproductive sys-
tem (McCarthy, 2008; Colvin & Abdullatif, 2013). Com-
pared to testosterone, much less research has been done on
the social and behavioural correlates of oestrogens, although
there is some evidence that oestradiol drives female
Fig. 5. Microbial regulation of social signalling molecules. Gut microbes regulate the biosynthesis of a range of molecules that
mediate social behaviour, including glucocorticoids such as corticosterone and cortisol, androgens such as testosterone, oestrogens
such as oestradiol, progestogens such as progesterone, monoamines such as serotonin and dopamine, and neuropeptides such as
oxytocin and arginine vasopressin. In addition to producing some of these molecules directly, gut microbes also alter their
concentrations and bioavailability via interactions with host tissue, or by secreting enzymes that deconjugate signalling molecules
into their active forms. There is evidence that gut bacteria can causally affect these signalling pathways. In addition, these
signalling molecules may in turn influence the microbial communities of the gut, either directly, by affecting other functions (such
as host immunity), as substrates used in microbial metabolism, or via microbial effects on host social behaviour which may
influence the probability of socially transmitted microbes entering the gut. In the case of progestogens such as progesterone and
monoamines such as serotonin, there is experimental evidence that these molecules can influence microbial populations directly.
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competition and status-seeking behaviour in humans (Knight
& Mehta, 2014; Stanton & Edelstein, 2009; Stanton &
Schultheiss, 2007).
Themicrobiome plays an important role in the availability
of oestrogens (Flores et al., 2012; Fuhrman et al., 2014), and
researchers have developed the concept of the ‘estrobolome’,
or the total collection of bacterial genes that encodes prod-
ucts capable of metabolising oestrogens (Plottel & Blaser,
2011). Disturbances in the estrobolome are thought to be
associated with breast cancer (Kwa et al., 2016). A significant
proportion of oestrogen molecules are hepatically conju-
gated with glucuronide or sulphate, rendering them inactive,
and their resultant polarity allows for re-entry into the lumen
and subsequent excretion (Kwa et al., 2016). This phenome-
non potentially prevents a substantial quantity of oestrogens
from exerting physiological effects. However, several bacte-
ria intervene in this process. For example, some bacteria
can influence the concentration of active oestrogen through
their capacity to encode enzymes such as β-glucuronidase
and β-glucosidase, which deconjugate oestrogen molecules
(Dabek et al., 2008; Kwa et al., 2016). This deconjugation of
oestrogen molecules into their active forms enables their
intestinal reabsorption and return to circulation. Thus, gut
microbes can enhance the bioavailability of oestrogens
beyond the host’s intrinsic capacity. In humans, some early
studies found that antibiotic treatment increased the pres-
ence of conjugated oestrogens in faeces, suggesting that anti-
biotics could suppress microbially mediated deconjugation in
the gut, an effect observed in both females (Adlercreutz et al.,
1975; Martin et al., 1975) and males (Hämäläinen, Kor-
pela, & Adlercreutz, 1987). While of course these results
could be attributable to off-target effects of antibiotics, the
close association between the microbiome and host oestro-
gens does suggest that antibiotics may exert a potent effect
on the bioavailability of oestrogens via loss of microbial
enzymes necessary for the deconjugation of oestrogen
molecules.
(c) Progestogens
Researchers have also recently detected microbiome–
progestogen associations. Like oestrogens, progestogens are
‘female’ steroid hormones that contribute to female repro-
ductive processes (Colvin & Abdullatif, 2013). However, like
oestrogens, progestogens are also present in males in small
quantities and contribute to male biology. The primary
progestogen is progesterone, and others include 16α-hydro-
xyprogesterone, 3β-dihydroprogesterone, and 5α-dihydro-
progesterone. Progesterone is involved in female
reproduction and related processes, including regulation of
the menstrual cycle, maintenance of pregnancy, inhibition
of milk production during pregnancy, and breast develop-
ment. At the behavioural level, it has been suggested that
progesterone is involved in human social bonding and affili-
ation (Brown et al., 2009; Fleischman, Fessler, & Cholakians,
2015; Gangestad &Grebe, 2017; Schultheiss, Wirth, & Stan-
ton, 2004; Wirth & Schultheiss, 2006).
The host microbiome changes continuously over the
course of pregnancy, with particularly large differences
between the first and third trimesters (Koren et al., 2012).
Notably, recent work has found substantial progesterone-
associated changes in the microbiomes of both humans and
mice (Nuriel-Ohayon et al., 2019). Specifically, the relative
abundance of Bifidobacterium spp. increases in the later stages
of pregnancy (Nuriel-Ohayon et al., 2019). Subsequent anal-
ysis found that the presence of progesterone sharply elevated
the relative abundance of Bifidobacterium spp. both in vivo and
in vitro, suggesting that progesterone is able to alter microbial
composition (Nuriel-Ohayon et al., 2019).
(3) Neuropeptide hormones
(a) Oxytocin
Oxytocin is a neuropeptide hormone produced mainly in the
hypothalamus. It plays an evolutionarily conserved role in
mating and reproductive behaviour (Garrison et al., 2012;
Feldman, 2017). Oxytocin and oxytocin-like molecules per-
form these functions in animals ranging from invertebrates
such as nematodes (Garrison et al., 2012; Elphick, Mira-
beau, & Larhammar, 2018) to humans (Feldman, 2017). At
the psychological level, oxytocin plays a prominent role in
mammalian social attachment, beginning with the mother–
infant bond, followed by bonds with other social partners as
the mammal matures (Feldman, 2017). There has also been
a great deal of interest in the prosocial effects of oxytocin,
particularly following the finding that exogenously adminis-
tered oxytocin promotes interpersonal trust (Kosfeld et al.,
2005). However, subsequent studies have failed to replicate
this result (Lane et al., 2015; Nave, Camerer, & McCullough,
2015), and at the very least, the oxytocin! trust relationship
is not as straightforward as originally anticipated. Moreover,
it is currently believed that it is not possible for peripheral
oxytocin to cross the blood–brain barrier to exert effects on
the central nervous system (Ermisch et al., 1985; Leng & Lud-
wig, 2016).
A range of studies suggests that the gut microbiome can
influence oxytocin signalling (Erdman & Poutahidis, 2016).
Antibiotic administration reduces hypothalamic oxytocin
levels in mice, alongside depleting microbial populations
(Desbonnet et al., 2015). As discussed earlier, the offspring
of mice fed high-fat diets during pregnancy display significant
social impairments and have fewer hypothalamic oxytocin-
expressing neurons, attributable to maternal diet-induced
differences in their gut bacteria (Buffington et al., 2016).
Moreover, early ingestion of the probiotic Lactobacillus reuteri
in the offspring restored the number of oxytocin-expressing
neurons in the mice and attenuated the social deficits.
Treatment with Lactobacillus reuteri also increased the num-
ber of oxytocin-positive neurons and their oxytocin expres-
sion in the paraventricular nucleus of Shank3-knockout
mice, which otherwise had fewer such neurons in this brain
region (Sgritta et al., 2019). Furthermore, the social benefits
of Lactobacillus reuteri are dependent on oxytocinergic
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signalling in the ventral tegmental area. Specifically,
Shank3-knockout mice lacking oxytocin receptors in dopa-
mine neurons did not show improvements in their
impaired social behaviour, and also did not show normal
levels of long-term potentiation in the ventral tegmental
area following social interaction (Sgritta et al., 2019). As
such, the capacity of this probiotic to exert effects on host
social behaviour appears to depend on the integrity of the
oxytocin signalling system. As mentioned earlier, vagot-
omy abolished the beneficial effects of Lactobacillus reuteri,
suggesting that the vagus nerve mediates this relationship.
Beyond these central effects, administration of Lactobacillus
reuteri to mice has also been found to upregulate plasma
oxytocin levels via the vagus nerve (Poutahidis
et al., 2013).
Interestingly, Lactobacillus reuteri appears to increase both
oxytocin and testosterone signalling, and also suppresses
glucocorticoid signalling (Poutahidis et al., 2013; Buffing-
ton et al., 2016; Varian et al., 2017). The mechanism by
which a single probiotic exerts effects on both neuropep-
tides and steroids remains unknown, although one possi-
bility is that these effects occur via changes in the
immune system. Also, given the involvement of the hypo-
thalamus in these signalling pathways, and since the gut
microbiome has been shown to affect the hypothalamus
(Buffington et al., 2016), it is plausible that Lactobacillus reu-
teri produces these effects by modulating hypothalamic
function.
(b) Arginine vasopressin
Arginine vasopressin (vasopressin) is a neuropeptide hor-
mone that is structurally similar to oxytocin, and, like oxyto-
cin, is produced mainly in the hypothalamus. Amongst the
primary physiological functions of vasopressin are the control
and regulation of the organism’s water balance and cardio-
vascular function (Share, 1988; Nielsen et al., 1995). Like oxy-
tocin, systemic vasopressin is unable to cross the blood–brain
barrier. At the psychological level, vasopressin has been
implicated in maternal behaviour. For example, in rodents,
vasopressin promotes maternal aggression towards intruders
(Bosch &Neumann, 2010). Central vasopressin has also been
found to be positively associated with sociability in monkeys,
with some evidence of a similar association in humans as well
(Parker et al., 2018). In general, the microbiome–vasopressin
relationship has not received as much attention as the
microbiome–oxytocin relationship. However, some interest-
ing patterns have been observed that suggest this may be a
worthwhile area of investigation. For instance, the adminis-
tration of antibiotics to mice reduces hypothalamic vasopres-
sin expression (Desbonnet et al., 2015). There is also recent,
intriguing evidence from rats that deletion of the Avp gene
(which controls vasopressin expression in the brain) leads to
sex-specific changes in the composition of the microbiome,




The indolamine serotonin (5-hydroxytryptamine) is a
metabolite of the essential amino acid tryptophan. Seroto-
nin regulates a variety of physiological processes in the
host, including normal gastrointestinal, cardiovascular,
and excretory functions (Berger, Gray, & Roth, 2009). In
terms of host psychological processes, the serotonergic sys-
tem is implicated in emotion regulation, social cognition,
and social interaction (Young & Leyton, 2002; Canli &
Lesch, 2007). Serotonergic signalling is also implicated in
social dominance and aggression across the animal king-
dom (Nelson & Chiavegatto, 2001). Serotonergic dysfunc-
tion has also been linked to psychiatric disorders such as
depression (Owens & Nemeroff, 1994). However,
researchers are discovering that the aetiology of depression
extends well beyond serotonergic disruption, and there is
increasing evidence that clinical depression is a highly het-
erogeneous disorder with multiple, intertwined aetiologies
linked to alterations in brain plasticity and monoamine
functions in general, as well as disturbances in the immune
system and the HPA axis (Miller & Raison, 2016; Pariante,
2017; Levy et al., 2018).
There has been a great deal of interest in the association
between the microbiome, tryptophan metabolism, and the
regulation of host serotonergic signalling (O’Mahony et al.,
2015). Compared to normally colonised mice, male germ-
free mice were found to have substantially higher levels of
plasma tryptophan, but substantially lower levels of plasma
serotonin, suggesting that the absence of gut microbes
impairs the peripheral conversion of tryptophan into seroto-
nin (Wikoff et al., 2009; Clarke et al., 2013). Microbial transfer
via faecal transplants from normally colonised mice to germ-
free mice is sufficient to increase peripheral serotonin con-
centrations within a few days of colonisation (Hata et al.,
2017). On the other hand, male (but not female) germ-free
mice also have significantly increased concentrations of sero-
tonin in the hippocampus (Clarke et al., 2013) and increased
serotonin turnover in the striatum (Diaz Heijtz et al., 2011).
This gives rise to an important conceptual puzzle: why –
and through what mechanism – does the absence of gut bac-
teria increase central serotonin levels (Clarke et al., 2013) and
its turnover (Diaz Heijtz et al., 2011), but decrease peripheral
serotonin levels (Clarke et al., 2013; Wikoff et al., 2009)? Fur-
thermore, are these changes related to one another, and do
they occur via a compensatory mechanism? Two of these
studies (Clarke et al., 2013; Wikoff et al., 2009) used Swiss
Webster mice, and therefore species-level variations in
genetic background are less likely to account for such differ-
ences between peripheral and central serotonin levels. One
possibility relates to the potential role of serotonin in meeting
the brain’s energy demands. In particular, researchers have
recently hypothesised that one of the primary functions of
serotonin in the brain is to support and regulate its energetic
and metabolic requirements, including in the hippocampus
(Andrews et al., 2015). If this is correct, then the enhanced
Biological Reviews 95 (2020) 1131–1166 © 2020 The Authors. Biological Reviews published by John Wiley & Sons Ltd on behalf of Cambridge Philosophical
Society.
1146 Amar Sarkar et al.
hippocampal serotonin concentrations in germ-free mice
(Clarke et al., 2013) might be attributable to central-level dif-
ferences in energy demands between germ-free and normally
colonised mice. One of the key roles of the microbiome is the
regulation of host peripheral metabolism (Turnbaugh et al.,
2006; Nicholson et al., 2012; Perry et al., 2016), and it could
be plausible that the microbiome also influences metabolism
in the central nervous system. At the very least, this hypothe-
sis warrants experimental investigation.
The mechanisms underlying serotonin differences in
germ-free and normally colonised animals are still under
investigation. One possibility is that the microbes themselves
generate a considerable quantity of serotonin. Indeed, bacte-
ria including species of Candida, Enterococcus, Escherichia, and
Streptococcus are capable of secreting serotonin directly (Lyte,
2011), although it is unknown whether, and to what extent,
this occurs in the gut environment (Johnson & Foster,
2018). A recent investigation found that indigenous spore-
forming bacteria (and particularly those from the genus
Clostridium) can regulate the host’s gut-based serotonin bio-
synthesis (Yano et al., 2015). These bacteria produce metab-
olites such as SCFAs that promote serotonin production by
the host’s enterochromaffin cells (Reigstad et al., 2015; Yano
et al., 2015). Thus, it may be that the majority of bacterial
contributions to host serotonin arise from bacterially derived
metabolites regulating the production of serotonin by the
host’s enterochromaffin cells, rather than from serotonin
directly produced by the bacteria themselves. Furthermore,
recent research also suggests that much of the luminal seroto-
nin in germ-free mice is conjugated with glucuronide and is
rendered biologically inactive (Hata et al., 2017). Bacterially
derived enzymes deconjugate glucuronidated serotonin mol-
ecules, increasing the total amount of bioavailable serotonin
in the lumen (Hata et al., 2017).
Importantly, as systemic serotonin is thought to be unable
to cross the blood–brain barrier, it is currently unclear
whether microbially derived peripheral serotonin is able to
affect the activity of the central nervous system directly.
The general implications of free luminal serotonin are pres-
ently unclear. However, a proportion of this serotonin may
be used in bacterial metabolism. In particular, there is evi-
dence that serotonin may promote the growth of some bacte-
ria (Roshchina, 2016). If serotonin is able to stimulate the
growth of particular bacterial taxa, then deconjugating seroto-
nin molecules in the lumen into free serotonin might directly
enhance the fitness of these bacteria by enhancing their growth
and reproduction. A recent study has shown that enhancing
serotonin levels using pharmacological and genetic manipula-
tions substantially increases the abundance of Clostridia spp.
and Turicibacter spp., suggesting that some gut bacteria are able
to detect and respond to serotonin as a growth factor (Fung
et al., 2019). In particular, Turicibacter sanguinis was found to pos-
sess genetic adaptations that enable serotonin importation. This
helps the bacterium gain an advantage over other bacteria in
colonising the gastrointestinal tracts of mice supplemented with
serotonin. On the other hand, the drug fluoxetine (a selective
serotonin reuptake inhibitor frequently used as an
antidepressant) reduces the capacity of Turicibacter sanguinis to
utilise host serotonin by inhibiting its serotonin-importer system,
thereby reducing its competitive advantage. Interestingly, when
miceweremonoassociatedwithTuricibacter sanguinis, supplemen-
tation with serotonin did not enhance bacterial growth. This
suggests that serotonin supplementation is only advantageous
whenTuricibacter sanguinis faces competition from othermicrobes
in colonising the gut (Fung et al., 2019).
(b) Dopamine
Gut microbes have also been noted to influence the concen-
trations of the endogenous catecholamine dopamine
(3,4-dihydroxyphenethylamine), which is synthesised from
its precursor, the amino acid levodopa (l-3,-
4-dihydroxyphenylalanine), which is itself synthesised from
tyrosine (4-hydroxyphenylalanine) (Nagatsu, Levitt, & Uden-
friend, 1964; Shiman, Akino, & Kaufman, 1971). Levodopa
(which is also used pharmacologically to treat Parkinson’s dis-
ease) occurs naturally in the body. It is able to cross the
blood–brain barrier, where it is converted into dopamine.
Peripheral dopamine, however, cannot cross the blood–
brain barrier.
The physiological roles of dopamine include motor con-
trol and coordination (Howe & Dombeck, 2016), as well as
the regulation of cardiovascular and renal function
(Goldberg, 1972). At the psychological level, dopamine is
best known for its role in the reward system, where it plays
a fundamental part in reward learning and prediction
(Schultz, 2002). Central dopaminergic signalling in brain
regions such as the striatum and ventral tegmental area is also
thought to facilitate social bonding by enhancing the reward
value of social interaction (Feldman, 2017), and some evi-
dence from dopamine receptor genetics suggests a role for
dopamine in the size and maintenance of human social net-
works (Pearce et al., 2017).
Comparisons between germ-free and normally colonised
mice have found that germ-free specimens show reduced
levels of luminal dopamine (Velagapudi et al., 2010; Asano
et al., 2012). Moreover, a substantial proportion of luminal
dopamine in germ-free mice was conjugated with glucuro-
nide or sulphate and biologically inactive, whereas the
reverse pattern was observed in normally colonised mice
(Asano et al., 2012). Both conventionalisation with a nor-
mal microbiome and colonisation with Clostridium spp.
increased levels of dopamine and β-glucuronidase. More-
over, comparisons between mice colonised with Escherichia
coli (capable of secreting β-glucuronidase) and mice colo-
nised with an Escherichia coli mutant (incapable of produc-
ing β-glucuronidase) revealed that luminal dopamine in
mice colonised with the mutant strain (in which
β-glucuronidase production was suppressed) was conju-
gated and biologically inactive, suggesting a causal role
for bacterially derived β-glucuronidase activity in regulat-
ing luminal dopamine availability.
Another example of microbial metabolism influencing the
availability of dopamine in the gut is a recent study reporting
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that gut bacteria metabolise exogenously administered levo-
dopa into dopamine, and then convert dopamine into m-
tyramine (Maini Rekdal et al., 2019). Specifically, Enterococcus
faecalis converts levodopa into dopamine via a decarboxyl-
ation reaction, and Eggerthella lenta converts dopamine into
m-tyramine via a dihydroxylation reaction (Maini Rekdal
et al., 2019). The implications of this phenomenon for central
dopamine levels are presently unclear. It may be that gut
microbes such as Enterococcus faecalis convert naturally occur-
ring levodopa to dopamine which might therefore lead to
reduced central dopamine availability in the brain (since
dopamine cannot cross the blood–brain barrier, unlike its
precursor levodopa). Further research is necessary to exam-
ine whether the natural conversion of levodopa to dopamine
by gut bacteria has a significant effect on dopamine levels in
the brain.
Researchers have also observed direct relationships
between the microbiome and central dopamine activity.
For instance, studies have found an increased concentration
of brain dopamine in germ-free mice (Matsumoto et al.,
2013; Nishino et al., 2013). Compared with normally colo-
nised conspecifics, germ-free mice also showed elevated hip-
pocampal expression of mRNA encoding D1, a key
dopamine receptor (Diaz Heijtz et al., 2011), as well as ele-
vated levels of striatal dopaminergic turnover (Diaz Heijtz
et al., 2011). However, enhanced central dopamine turnover
has not consistently been observed. For instance, one study
comparing germ-free and normally colonised rats found lower
dopaminergic turnover in the frontal cortex, hippocampus,
and striatum in germ-free specimens (Crumeyrolle-Arias
et al., 2014).
Clearly, while additional studies are needed to clarify the
role of the microbiome in dopaminergic turnover, the avail-
able data at least suggest that the microbiome can influence
central dopaminergic signalling. Moreover, Sgritta et al.
(2019) found that the probiotic-induced rescue of social defi-
cits in autistic-type mice required the presence of oxytocin
receptors on dopamine neurons in the ventral tegmental
area. Thus, alongside oxytocinergic signalling, dopaminergic
signalling also appears to be necessary for the benefits of Lac-
tobacillus reuteri.
VI. MICROBIAL REGULATION OF GENE
EXPRESSION AND EPIGENETIC PROCESSES IN
THE SOCIAL BRAIN
There is growing interest in microbial contributions to social
behaviour at the level of host gene expression and epigenetic
mechanisms (Stilling et al., 2014). In particular, if the micro-
biome is affecting brain morphology and function and hor-
monal and neurotransmitter signalling, then it can be
expected that the microbiome also influences host gene
expression. In this regard, research is now revealing that
the microbiome can modulate gene activity relevant to
sociality.
(1) Neuroanatomical distribution of gene expression
Relative to normally colonised mice, germ-free mice show
extensive dysregulation in networks of micro-ribonucleic
acids (miRNAs) in the amygdala and prefrontal cortex, both
key regions of the social brain (Hoban et al., 2017). Some, but
not all, of these aberrations were attenuated by colonisation
with a normal microbiome (Hoban et al., 2017). Further-
more, gene expression profiling in the amygdalas of germ-
free mice (compared to normally colonised mice) revealed
elevated expression of transcription factor genes (Fos, Egr2,
Nr4a1) and the genes Arc and Homer1 that are indices of
increased BDNF signalling and neuronal activation, respec-
tively (Stilling et al., 2015).
The absence of microbes is associated with other pre- and
post-transcriptional events including differential exon splic-
ing and editing of mRNAs that ultimately sculpt changes in
neuronal function (Hoban et al., 2017, 2018; Stilling et al.,
2018). These studies found that the expression of transcrip-
tion factor genes and genes involved in neuronal activity were
elevated in the amygdalas of both germ-free and normally
colonised mice that had recently engaged in social interac-
tions, suggesting that social interaction rapidly affects amyg-
dalar gene expression. Importantly, however, the amygdalar
neurons of germ-free animals displayed higher rates of alter-
native splicing (Stilling et al., 2018), a process that expands the
number of proteins that could otherwise be encoded by a
given number of genes, ultimately increasing the range of
biological functions those genes can perform. Furthermore,
in germ-free mice, there is enhanced expression of genes reg-
ulating cholinergic and dopaminergic neurotransmission,
which are associated with amygdalar learning (Hoban
et al., 2018).
These changes in splicing and expression observed in
germ-free animals likely represent aberrant alterations in
host genetics as a result of the absence of microorganisms.
For example, we might speculate that these variations in
splicing and gene expression reflect compensatory pro-
cesses initiated by the host, such that functions which
would otherwise be supported by microbiome-related
activity can be fulfilled in the absence of microbes.
Another possibility is that this increased alternative splic-
ing is maladaptive, and is kept in check by microbiome-
related processes.
Overall, germ-free mice show deficits in social develop-
ment (Desbonnet et al., 2014; Buffington et al., 2016; Stilling
et al., 2018) and there is evidence of an association between
aberrant gene expression and neuronal function in the amyg-
dalas of germ-free animals in response to social challenges
(Stilling et al., 2018). For instance, an enrichment of RNA-
splicing genes – but not those involved in mitogen-activated
protein kinase (MAPK) cell signalling pathways – was
observed in germ-free mice following social interaction
(Stilling et al., 2018).
Based on these observations, it is reasonable to speculate
that perturbations of the microbiome in normally colonised
animals may impact their social behaviour via changes in
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gene and protein expression. For example, antibiotic-
induced dysbiosis in mice reduced both social recognition
and hippocampal BDNF levels, but elevated the expression
of the BDNF receptor, tropomyosin receptor kinase B
(TrkB) (Guida et al., 2018). Furthermore, ingestion of the pro-
biotic Lactobacillus casei normalised both central BDNF levels
and social recognition memory, although TrkB densities
remained elevated (Guida et al., 2018). However, it should
be noted that the design of this study did not permit examina-
tion of the possibility that TrkB density simply requires lon-
ger to return to normal. The capacity of this single-strain
probiotic to rescue deficits in social recognition from
antibiotic-induced dysbiosis suggests the possibility that dis-
crete changes in a complex microbial community may be
able to affect brain function, although of course these effects
may occur via other pathways, such as modulation of the
immune system.
(2) Epigenetic effects of glucocorticoids
It remains unclear what causes changes in central gene
expression. One possibility is that the peripheral neuroendo-
crine stress response, mediated by the HPA axis, is a key link
between gut microbes and host behaviour (Cryan & Dinan,
2012; Foster & McVey Neufeld, 2013; de Weerth, 2017).
Glucocorticoids (which are elevated in circulation during
stressful events) enter the brain and bind to glucocorticoid
receptors which are abundantly expressed in the hippocam-
pus and amygdala. Within the cell nucleus, the ligand-bound
glucocorticoid receptors can affect transcription by direct
high-affinity binding to glucocorticoid response elements
found either in the promoters or the intragenic regions of glu-
cocorticoid target genes (Tan & Wahli, 2016). Therefore, a
heightened stress response is likely to result in changes in
activity of hippocampal and amygdalar neurocircuitry, with
subsequent changes in social behaviour. Consistent with this
supposition, the activation of hippocampal glucocorticoid
receptors has been shown to enhance contextual fear mem-
ory via elevation of BDNF signalling (Revest et al., 2014). This
result corroborates the observation that germ-free mice have
increased amygdalar BDNF levels, which is accompanied by
an exaggerated stress response (Sudo et al., 2004). Of course,
the mechanisms via which the microbiome can regulate
HPA-axis activity are still being elucidated, and potentially
include microbiome interactions with the gut immune system
and the enteric nervous system (e.g. through direct contact or
neurotransmitters secreted by bacteria, as described earlier
in Section V).
(3) Epigenetic effects of microbial metabolites
Some of the microbial effects on host physiology may also be
orchestrated by the metabolites that the microbes generate
from breaking down complex dietary carbohydrates in the
host’s diet. For example, the fermentation of indigestible car-
bohydrates by the gut microbiome produces SCFAs (Koh
et al., 2016; Sarma et al., 2017), which can then enter systemic
circulation and modulate sympathetic nervous system activ-
ity (Kimura et al., 2011). Microbially generated SCFAs
include acetate, butyrate, and propionate. Of these, most of
the butyrate is readily absorbed by epithelial cells of the colon
where it is utilised as an energy source, and promotes anti-
inflammatory responses (Koh et al., 2016). While propionate
and a proportion of the acetate bind to specific receptors in
the gut and initiate the release of gut hormones (Koh et al.,
2016), the majority of acetate is taken up into the vascular
system and distributed throughout the organs, including the
brain (Koh et al., 2016; Perry et al., 2016). Glial cells can
use acetate as a source of energy, but more importantly,
this SCFA can exert epigenetic effects through the inhibi-
tion of histone deacetylases (Rae et al., 2012). That is, ace-
tate promotes the process that allows the transcription of
genes to occur. More specifically, acetate is an inhibitor
of histone deacetylases that remove acetate groups from
genomic DNA and hinder the dissociation of the double-
stranded molecule that must occur prior to gene
transcription (Kasubuchi et al., 2015). Thus, in general,
the inhibition of histone deacetylases increases gene
expression. Like acetate, butyrate is also a potent histone
deacetylase inhibitor, and accordingly may impact gene
expression in the gut since this is where it is largely
absorbed (Koh et al., 2016). However, since butyrate can
cross the blood–brain barrier, its epigenetic effects may
also extend to the brain.
In rats, both the oral administration of acetate and the
intake of bifidogenic oligosaccharides (prebiotics) can
increase the circulating concentrations of acetate, as well as
the expression of genes encoding central glutamate N-
methyl-D-aspartate (NMDA) receptor subunits and BDNF
(Savignac et al., 2013; Gronier et al., 2018). Prebiotic feeding
has also been shown to enhance the function of brain NMDA
receptors, and improve cognitive flexibility in rats (Gronier
et al., 2018). These findings are consistent with an earlier
study showing that oral acetate supplementation rescued
impairments in NMDA receptor function and, importantly,
was associated with the inhibition of histone deacetylase
activity (Singh et al., 2016). Therefore, one hypothesis is that
acetate is a mediator of the procognitive effects of prebiotics,
although this has yet to be formally tested. With regard to
social behaviour, one investigation demonstrated that the
inhibition of histone deacetylase activity in Syrian hamsters
exacerbated behavioural responses to social stress, suggesting
that epigenetic gene silencing may be favourable for the
maintenance of normal social interactions (McCann et al.,
2017). However, the inhibitor in this instance was sodium
butyrate that was systemically or centrally administered at
pharmacological doses (McCann et al., 2017), and therefore
was not representative of the quantity and anatomical distri-
bution of this SCFA when it is derived from the gut
microbiome.
These findings collectively suggest the effects of the micro-
biome on host RNA biology and post-transcriptional pro-
cesses, and provide evidence of potential microbial
contributions to the genetic basis of social behaviour.
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VII. THE MICROBIOME AND SOCIAL
OLFACTORY SIGNALS
The olfactory system plays an important role in conveying
and detecting social information across the animal kingdom
(Steiger, Schmitt, & Schaefer, 2011). The olfactory system
participates in a variety of social processes, including territo-
rial marking, discriminating between social groups, kin rec-
ognition, and mate detection and attraction. As just one
example, in spotted hyaenas (Crocuta crocuta) a subcaudal
gland secretion known as hyaena ‘paste’ relays a range of
social information used for intra-specific signalling and com-
munication (Drea et al., 2002a, 2002b; Burgener et al., 2009),
including as a marker of social rank (Burgener et al., 2009).
(1) The fermentation hypothesis
The fermentation hypothesis proposes that olfactory signals
are the products of bacterial metabolism which the host
exploits for chemical communication (Albone et al., 1974;
Albone & Perry, 1976). These bacterially produced odour-
ants may be generated in dedicated scent glands, and can
be present in faeces, urine, or other secretions. Researchers
are now finding, consistent with the fermentation hypothesis,
that bacterial metabolism generates a range of odourants
which communicate important social information, including
sex, kinship, fertility, lactation status, health, and group
membership via the olfactory system (Lizé, McKay, & Lewis,
2013; Ezenwa & Williams, 2014; Archie & Tung, 2015;
Vuong et al., 2017; Bienenstock, Kunze, & Forsythe, 2018;
Carthey, Gillings, & Blumstein, 2018).
(2) A microbiome–olfaction–behaviour pathway?
Researchers have recently suggested that the microbiome–
gut–brain axis may entail an underappreciated olfactory
component – in other words, a microbiome–olfaction–
behaviour pathway (Bienenstock et al., 2018). This olfactory
component comprises the system of olfactory receptors and
odourants, the molecules that bind to them. Olfactory recep-
tors are widely distributed in the body. They are encoded by
extensive multigene families, and are evolutionarily con-
served across the animal kingdom. For example, the olfactory
receptor multigene family comprises approximately
100 genes in catfish (Ngai et al., 1993), over 900 genes in mice
(Godfrey, Malnic, & Buck, 2004), and over 300 genes in
humans (Malnic, Godfrey, & Buck, 2004). In addition to
the classical odour receptors, two new types of receptors have
also been found to be involved in olfaction: trace-amine asso-
ciated receptors and formyl peptide receptors (Bienenstock
et al., 2018).
Importantly, host-associated microbes are capable of gen-
erating a number of odourants that bind to these receptors
(i.e. classical odourant receptors, trace-amine associated
receptors, and formyl peptide receptors), thereby modulating
host tissue (Bienenstock et al., 2018). As such, some of the
behavioural effects of the microbiome may be mediated by
this broadly expressed system of olfactory receptors
(Bienenstock et al., 2018). This microbiome–olfaction cou-
pling may make larger contributions to host social behaviour
than currently appreciated.
(3) Insects
A relatively well-established body of research demonstrates
that host-associated bacteria influence chemosignalling and
communication between conspecifics by modulating odour
profiles in insects. Bacterial effects on individual or colony-
level chemical profiles, with subsequent effects on behaviour,
have been observed across a range of insects, including ants
(Acromyrmex echinatior; Dosmann, Bahet, & Gordon, 2016),
cockroaches (Blattella germanica; Wada-Katsumata et al.,
2015), fruit flies (Drosophila melanogaster; Sharon et al., 2010;
Venu et al., 2014), locusts (Schistocerca gregaria; Dillon, Ven-
nard, & Charnley, 2000, 2002), and termites (Hodotermes mos-
sambicus; Minkley et al., 2006).
Bacteria facilitate the production of guaiacol, an insect
aggregation pheromone that supports swarming behaviour,
as observed in locusts (Schistocerca gregaria) (Dillon et al.,
2000). Interestingly, more recent research suggests that
swarming behaviour in the same locust species is also medi-
ated by serotonin, which plays a role in the behavioural gre-
garisation that precedes swarming (Anstey et al., 2009). It
remains unknown whether the bacteria-associated,
guaiacol-mediated pathway underlying swarming is related
to the serotonin-mediated pathway underlying gregarisation.
Indirect evidence for such a connection derives from studies
that investigate the effects of infection with the fungus Parano-
sema locustae, which both inhibits locust swarming behaviour
via acidification of the hindgut and supresses serotonin-
producing bacteria (Shi et al., 2014). In this regard, investigat-
ing the possibility of amicrobiome–guaiacol–serotonin system
supporting gregarisation and swarming in locusts would be
particularly interesting (Münger et al., 2018).
Microbially generated odours may also provide cues to
recognise colony members. For instance, experimental alter-
ation or disruption of the external microbiome of harvester
ants (Pogonomyrmex barbatus; Dosmann et al., 2016) and the
gut microbiome of lower termites (Reticulitermes speratus; Mat-
suura, 2001) interferes with nestmate recognition, leading to
rejection of colony members. The microbiome may also con-
tribute to insect reproductive behaviour. For example, it has
been suggested that fruit flies (Drosophila melanogaster) show
mating preferences for conspecifics with similar microbial
compositions, a social cue attributed to Lactobacillus plantarum
(Najarro et al., 2015; Sharon et al., 2010; but see Leftwich
et al., 2017; see also Rosenberg et al., 2018).
(4) Non-human mammals
Host-associated microbial populations in the gut or other
dedicated scent-producing structures also contribute to
mammalian social olfaction. Early observations of this phe-
nomenon were made in the anal scent pouches of mongooses
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(Herpestes auropunctatus) (Gorman, Nedwell, & Smith, 1974;
Gorman, 1976) and red foxes (Vulpes vulpes) (Albone et al.––
1974; Albone & Perry, 1976). More recent work has exam-
ined bacterially mediated social olfaction in hyaenas.
The compounds in the scent gland secretions (paste) of
spotted hyaenas contain bacterially derived odourants that
are associated with the signalling of important social infor-
mation (Theis et al., 2013), including host sex, immigration
status in males, and pregnancy and lactation status in females
(Theis et al., 2013). Furthermore, social groups of hyaenas are
distinguishable on the basis of these bacterially generated
odour profiles (Theis, Schmidt, & Holekamp, 2012; Theis
et al., 2013). Other mammals in which microbial composition
appears to correlate with social olfaction include badgers
(Meles meles) (Sin et al., 2012; Noonan et al., 2019), meerkats
(Suricata suricatta) (Leclaire, Nielsen, & Drea, 2014; Leclaire
et al., 2017), and elephants (Loxodonta africana and Elephas max-
imus) (Goodwin et al., 2012).
Experimental efforts in rodents have begun elucidating the
odourant molecules that are sensitive to the presence of
microbes. For instance, the murine microbiome generates
trimethylamine, which acts as an attractive olfactory cue.
Antibiotic treatment reduces trimethylamine production,
causing mice to become less sexually attractive to conspecifics
(Li et al., 2013). Moreover, the urine of germ-free rats appears
to lack biochemicals that are involved in individual identifica-
tion based on odour discrimination (Singh et al., 1990),
although this reduction in microbially derived odourants
may not be sufficient to inhibit reproductive behaviour con-
sistently (Nielsen et al., 2019).
(5) Humans
At present, it is not known whether bacteria affect human
social perception or social interaction viamodulation of social
olfaction. There is some evidence that the skin microbiome
may contribute to human odour profiles, but overall, the
association is weak at best and appears to be very sensitive
to behaviours (e.g. bathing, deodorant use) and external fac-
tors (Xu et al., 2007). There is also evidence that the human
skin microbiome produces compounds that act as attractants
for mosquitoes, including the malaria mosquito Anopheles gam-
biae sensu stricto (Verhulst et al., 2010a, 2010b). These mosqui-
toes rely on odour profiles to target potential hosts, and both
the composition of the skin microbiome and the compounds
it produces can influence odour profiles and therefore the
host’s attractiveness to mosquitoes (Verhulst et al., 2010a,
2010b, 2011). Overall, these results suggest that microbes
affect human odour profiles. The finding that microbes con-
tribute to human odour has implications for host health and
infection, but it cannot necessarily be inferred that this micro-
bial influence on odour profiles extends to human social per-
ception or social interaction. While some studies do suggest a
role for pheromones in human social interaction
(Gildersleeve et al., 2012; Frumin et al., 2015), further
research is required to determine the existence and effects
of human pheromones (Wyatt, 2015).
VIII. MICROBIAL ASSOCIATIONS WITH
EMOTION AND SOCIAL BEHAVIOUR IN
HUMANS
(1) Psychobiotic studies
Compared to the relatively clearer psychobiotic effects on
rodent behaviour, human research has not found consistent
psychological benefits of probiotic consumption (Kelly et al.,
2017). However, there are some important parallels with
rodent findings. For example, consumption of psychobiotics
lowers cortisol levels (Messaoudi et al., 2011; Schmidt et al.,
2015; Allen et al., 2016) and is accompanied by self-reported
reductions in negative mood (Messaoudi et al., 2011; Steen-
bergen et al., 2015). In a recent double-blind, randomised
psychobiotic administration experiment, Bifidobacterium
longum 1714 consumed over a four-week period was found
to affect brain activity associated with the psychological stress
induced by social exclusion, as measured by magnetoenceph-
alography (Wang et al., 2019). Relative to participants treated
with a placebo, those treated with the psychobiotic displayed
increased resting-state θ power in the frontal and cingulate
cortices, and reduced β2 power in the hippocampus, the fusi-
form gyrus, the temporal cortex, and the cerebellum (Wang
et al., 2019). In response to the social task, participants treated
with the psychobiotic (relative to the placebo) also showed
increased power in the θ and α bands in several brain regions,
including the inferior, medial, and superior frontal cortices,
the anterior and middle cingulate cortices, and the supra-
marginal gyrus (Wang et al., 2019). While these results cannot
necessarily be linked to a particular psychological state or
experience, they do suggest that psychobiotics may be capa-
ble of modulating brain activity both at rest and in response
to social experiences. However, as with most other human
studies, the sample sizes were relatively small.
We have hypothesised that one mechanism underlying
some of the psychological effects of psychobiotics may be a
generalised decrease in social–emotional reactivity (Sarkar
et al., 2018). For example, consuming probiotics has been
found to reduce activity in a brain network associated with
processing emotional information in response to facial stim-
uli (including the amygdala) (Tillisch et al., 2013), and
another study showed that probiotic consumption reduced
psychological reactivity to sadness (Steenbergen et al.,
2015). There is also evidence that prebiotics can reduce wak-
ing cortisol levels and emotional attention to negative stimuli
(Schmidt et al., 2015).
(2) Microbiome–depression associations
Disorders of emotion, such as depression, often exert pro-
found effects on normal human social behaviour, and are
characterised by a loss of interest in pleasurable activities
(including social interactions) as well as social withdrawal
and isolation. There is much interest in characterising emo-
tional disorders in terms of consistent bacterial signatures.
For instance, depression has recently been associated with
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changes in the relative abundance of numerous bacterial
taxa. These include increases in the Firmicutes phylum,
decreases in the Bacteroides phylum, and increases in the
genera Prevotella, Klebsiella, Streptococcus and Clostridium (Lin
et al., 2017). Others have found increases in the Enterobac-
teriaceae family and the Alistipes genus and decreases in the
Faecalibacterium genus in depressed individuals relative to
healthy controls (Jiang et al., 2015), or order-level increases
in Bacteriodales and family-level increases in Lachnospira-
ceae (Naseribafrouei et al., 2014). Some studies have found
increases in Actinobacteria and Proteobacteria in depressed
individuals (Jiang et al., 2015; Zheng et al., 2016).
Comparing studies reveals some contrasting results, with
studies reporting evidence of depressed individuals showing
both higher (Naseribafrouei et al., 2014; Jiang et al., 2015)
and lower (Zheng et al., 2016) levels of Bacteroidetes. In some
cases, the abundance of particular bacterial taxa correlates
with the severity of depression. For instance, a negative asso-
ciation was found between the relative abundance of Faecali-
bacterium spp. and the severity of depressive symptoms (Jiang
et al., 2015). Following up on the need for larger studies, a
recent metagenomic survey in two large European samples
reported evidence that depression is associated with reduced
levels of Coprococcus spp. and Dialister spp., even after control-
ling for antidepressant treatment (Valles-Colomer et al., 2019).
The psychological implications of variation in particular
bacterial communities for emotional disorders remain
rather unclear. At present, it is largely unknown how dif-
ferent bacterial communities might contribute to depres-
sion, although perhaps some cautious inferences can be
drawn from specific functions of bacteria that have been
examined in other contexts. For example, Alistipes spp.
may be linked to increased inflammation (Naseribafrouei
et al., 2014), which is often a prominent physiological
marker of depression (Miller, Maletic, & Raison, 2009).
Other recent research has found that several human-
associated bacterial genera produce GABA or use it as a
nutrient (Strandwitz et al., 2019). For instance, growth of
the bacterial isolate KLE1738 appears to depend on
GABA as a nutrient, which is produced by members of
the Bacteroides genus under pH conditions similar to the
human gut (Strandwitz et al., 2019). Moreover, in a small
sample of clinically depressed individuals, the relative
abundance of the genus Bacteroides was negatively corre-
lated with brain signatures of depression (Strandwitz
et al., 2019). Specifically, reduced Bacteroides abundance
was linked to stronger functional connectivity between
the left dorsolateral prefrontal cortex and the default
mode network (Strandwitz et al., 2019), and such increased
functional connectivity has previously been associated with
depression.
(3) Infancy and early development
There is strong interest in the changes in microbiome compo-
sition during infancy and early development. The mamma-
lian neonate’s microbiome is shaped by numerous
environmental influences, one of the first of which is breast-
milk (Allen-Blevins, Sela, & Hinde, 2015). Breastmilk pro-
vides, for instance, an important supply of prebiotic glycans
(human milk oligosaccharides) to the infant gut
(Charbonneau et al., 2016). In infants and young children,
microbial composition has been shown to correlate with tem-
perament and emotional regulation (Christian et al., 2015;
Aatsinki et al., 2019), as well as cognitive development and
linguistic skill (Carlson et al., 2018), which are beneficial for
social interaction.
One particularly important area in microbiome research
that may be relevant to the social–emotional development
of humans is the effect of early antibiotic exposure, given
the rising prevalence of antibiotic use (Blaser, 2016; Sonnen-
burg & Sonnenburg, 2019), especially among young children
(Cox & Blaser, 2015). For example, murine studies have
found that exposure to low doses of antibiotics during infancy
can permanently alter the host’s gut microbiome and endo-
crine physiology (Cho et al., 2012). In addition, antibiotic
treatment in young mice has been found to reduce the
expression of neuroreceptors implicated in social and emo-
tional behaviour, namely μ-opioid, oxytocin, and vasopressin
receptors (K.V.-A. Johnson & P.W.J. Burnet, in preparation).
In humans, antibiotic administration in early life has been
associated with greater incidence of depressive symptoms in
later childhood (Slykerman et al., 2015). Similarly, antibiotics
administered in early life were associated with negative out-
comes on measures of cognitive function even at 11 years of
age, after adjusting for other variables such as probiotic
exposure and breastfeeding (Slykerman et al., 2019). These
studies add inductive support to the hypothesis that a healthy
microbiome in early life is important for typical social–
emotional development in humans, and that antibiotics
may disrupt this development. However, these investigations
(Slykerman et al., 2015, 2019) did not directly examine anti-
biotic effects onmicrobial composition. Therefore, while var-
iations in subsequent psychological outcomes are certainly
consistent with the possibility of antibiotic-induced microbial
disturbances, they may also arise from modulation of non-
microbial targets. For example, they may be associated with
the many off-target effects of antibiotics, such as those
described in Section II. Alternatively, because antibiotics
are administered in response to infection, the observed
increase in childhood depression may be attributable to ele-
vated inflammation caused by the infection for which antibi-
otics were used in the first instance. This is plausible given
that inflammation and depression are often robustly associ-
ated (Dowlati et al., 2010), and that childhood inflammation
can predict future depression in young adults, even several
years later (Khandaker et al., 2014). Therefore, the finding
that antibiotic exposure predicted depressive symptoms
may simply indicate that the infants suffered from illness
(and inflammation), rather than the depressive symptoms
occurring in response to antibiotic-induced microbial pertur-
bations. Future studies of this type should also incorporate
analyses of the microbiome following antibiotic administra-
tion, which will provide a clearer understanding of the
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relationship between the microbial and psychological
changes associated with antibiotic use.
The infant microbiome may also be sensitive to prenatal
stress during pregnancy. For example, in the first 110 postna-
tal days, higher levels of maternal prenatal stress were found
to be associated with shifts in infant microbial composition
that, in turn, were associated with greater levels of inflamma-
tion and poorer health outcomes (Zijlmans et al., 2015).
These human results appear similar to murine findings. In
particular, it is important to keep in mind that maternal pre-
natal stress alters the vaginal microbiome (Jašarevic, Morri-
son, & Bale, 2016). The vaginal microbiome is important in
this context because it is assumed to be the first microbial
exposure for mammalian infants, with vaginal microbes colo-
nising the infant gut microbiome during parturition
(Dominguez-Bello et al., 2010; Mueller et al., 2015; Sprockett
et al., 2018). A stress-associated vaginal microbiome in female
mice can be transmitted to the infant during birth, which in
turn can impact the developing infant’s health, metabolism,
and stress response (Jašarevic et al., 2015, 2018). While the
actual vertical transmission of stress-associated microbes has
not yet been observed in humans, researchers have detected
stress-associated microbial changes in the maternal human
gut during pregnancy (Hechler et al., 2019). In addition, it
has been shown that prenatal stress in pregnant monkeys
alters the microbial composition of the infant gut (Bailey,
Lubach, & Coe, 2004). Thus, it is plausible that vertical
transmission of stress-associated microbes to the infant dur-
ing vaginal births may occur in humans as well, with neuro-
developmental implications for the infant. Conclusive
evidence for this phenomenon would require longitudinal
studies of both maternal and infant microbiomes over time,
alongside tracking of maternal and infant stress.
(4) Potential prenatal microbial exposures
In humans (and mammals more generally) the conventional
view is that the womb is a germ-free environment. For mam-
mals, the earliest colonisation event is believed to occur dur-
ing parturition. The mother’s vagina serves as the infant’s
first source of microbes, and it is assumed that there is no
microbial exposure in utero.
Some researchers have questioned this ‘sterile womb’
hypothesis, suggesting that microbial exposures also occur
in utero (Funkhouser & Bordenstein, 2013). Researchers have
already identified a microbe! maternal physiology! foe-
tus pathway (i.e. indirect microbe–foetus contact, as studied,
for instance, by Kim et al., 2017). However, the possibility of
prenatal exposures dramatically changes the nature of
microbial influence on the foetus, as it would imply a mother
! microbe ! foetus pathway (i.e. direct microbe–foetus
contact), with the possibility of prenatal microbial colonisa-
tion. To this extent, researchers found what appeared to
be a unique placental microbiome (Aagaard et al., 2014;
Antony et al., 2015), which suggests that microbial popula-
tions might be able to reach and colonise the foetus. Others
have taken this possibility further by proposing the existence
of an amniotic microbiome and a foetal microbiome
(Collado et al., 2016; Martinez II et al., 2018). Such prenatal
microbial exposures, if they existed, could profoundly alter
the current understanding of mammalian developmental
biology.
However, these intriguing possibilities are challenged by
findings that the presence of microbes may instead result
frommethodological artefacts such as reagent contamination
(Lauder et al., 2016; Perez-Muñoz et al., 2017; Leon et al.,
2018; Lim, Rodriguez, & Holtz, 2018; de Goffau et al.,
2019; Theis et al., 2019). Moreover, it is also the case that
some potentially pathogenic microbes, such as Streptococcus
agalactiae, may indeed be capable of infecting the placenta,
with implications for neonatal health (de Goffau et al.,
2019). However, the presence of potential pathogens in the
placenta cannot be interpreted as evidence that there is also
an intrinsic or typical placental microbiome (comprising
mutualists, commensals, and pathobionts). Rather, Streptococ-
cus agalactiae appears to occur in a minority of cases, and its
presence is considered atypical and infectious (de Goffau
et al., 2019).
Bushman (2019) provides a useful historical overview of
the issues regarding the placental microbiome. At present,
the existence of placental, amniotic, or foetal microbiomes,
although intriguing, remains controversial and requires rig-
orous confirmatory evidence.
(5) Social behaviour and autism
Any effect of the microbiome on human sociality is expected
to occur through the mechanisms inferred from studies using
mammalian models. In practice, however, testing this associ-
ation will be extremely challenging, not least because of a
lack of adequate animal models of human social develop-
ment and the necessary ethical limitations of experimenta-
tion in humans (although primate models of the kind
described in Section III above may provide further insight).
There are few observations of microbial effects on human
social behaviour, though researchers are particularly inter-
ested in the microbiome–autism link, which entails analyses
of social behaviour by definition.
At the observational level, a number of studies have
attempted to differentiate between autistic and neurotypical
children on the basis of microbiome composition. For exam-
ple, surveys of autistic individuals have found decreased
levels of Coprococcus, Prevotella, and Veillonellaceae compared
to healthy controls (Kang et al., 2013), and elevations in Clos-
tridium (Finegold et al., 2002; Song, Liu, & Finegold, 2004;
Parracho et al., 2005) and Sutterella (Williams et al., 2011;
Wang et al., 2013). At the same time, there is also consider-
able variation and discrepancy in identifying bacterial
markers of autism. For example, the ratio of the Firmicutes
to Bacteroidetes phyla in autistic compared to non-autistic
children has been found to be elevated, reduced, or
unchanged in different studies (Finegold et al., 2010;Williams
et al., 2011; Kang et al., 2013; Son et al., 2015; Forsythe et al.,
2016). A recent systematic review of 16 studies did find cross-
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study evidence of some consistent microbial differences in
autistic individuals compared to neurotypical controls,
including increased Bacteroides, Clostridium, Desulfovibrio, Lacto-
bacillus, and Proteobacter, and decreased Bifidobacterium, Blautia,
Dialister, Prevotella, Veillonella, and Turicibacter (Liu et al., 2019).
At present, it is unclear how specific bacterial populations
might contribute to the pathophysiology of autism, but
researchers are attempting to characterise the physiological
roles that these bacteria play (e.g. modulation of inflamma-
tion and metabolism). This may then help researchers infer
how altered relative abundances in different bacterial popu-
lations may be used to characterise at least some of the fea-
tures of autism. In addition, a recent study employing
multiple regression analyses found that certain bacterial gen-
era previously associated with autism are also significantly
related to individual differences in sociability in neurotypical
adults, and in the same direction as typically found in autistic
individuals (Johnson, 2020). It has therefore been suggested
that the gut microbiome may contribute to variation in social
behaviour in the general population, as well as in autism
(Johnson, 2020).
The possibility that autismmay be associated with distinct
microbial profiles in humans has led to a great deal of inter-
est in modifying the microbiome in an attempt to target
autism-associated behaviours. These approaches have
yielded varying rates of success. For instance, one probiotic
administration study that implemented a double-blind,
crossover design failed to detect changes in behaviour in
autistic participants, but did observe some differences in
microbial composition (Parracho et al., 2010). In another
intervention study, researchers found that antibiotic treat-
ment with vancomycin over an eight-week period mitigated
behavioural phenotypes in a small sample of autistic chil-
dren (Sandler et al., 2000). However, these benefits were
transient, and were mostly absent within just 2 weeks follow-
ing vancomycin treatment, and were also absent at long-
term follow-ups (Sandler et al., 2000). Furthermore, though
some antibiotics may provide short-term benefits
(e.g. Sandler et al., 2000), it is likely unfeasible to engage in
chronic antibiotic treatment for autism, as there is presently
no way of controlling the detrimental effects on the micro-
biome, as well as the inevitable development of antibiotic
resistance that prolonged exposure would induce.
Recently, researchers have adopted a more direct
approach to modifying the microbiome: an open-label inves-
tigation in a sample of 18 autistic participants investigated
the efficacy of faecal transplants in treating gastrointestinal
and behavioural symptoms (Kang et al., 2017). In order to
deplete as many gut bacteria as possible, participants first
underwent broad-spectrum antibiotic treatment using van-
comycin for 2 weeks, and were then given a bowel cleanse
to remove any remaining bacteria and vancomycin. They
were also given an acid suppressant to reduce stomach acid-
ity, which would facilitate survival of orally administered
microbes. Following this, participants received faecal trans-
plants from neurotypical donors over several weeks (first at
a high initial dose that was delivered orally or rectally,
followed by lower maintenance doses administered orally).
More precisely, rather than transferring pure faecal matter,
donor faeces were used to generate a standardised human
gut microbiome, containing over 99% bacteria (Hamilton
et al., 2012). At the end of the treatment, participants showed
substantial improvement in both gastrointestinal symptoms
(e.g. diarrhoea and indigestion), and social deficits and other
behavioural features (e.g. repetitive behaviours). Participants
were also reported to have gained 1.4 years in developmental
age on measures of adaptive behaviours (e.g. communication
and living skills). These improvements were apparent
8 weeks following the cessation of treatment. In addition,
the researchers detected elevations in Bifidobacterium,Desulfovi-
brio, and Prevotella which also remained 8 weeks after treat-
ment (Kang et al., 2017). Even more striking were the
results of follow-up assessments conducted on these partici-
pants 2 years following the completion of the microbial trans-
plant: most of the gastrointestinal and behavioural
improvements had persisted through the intervening period,
and several of the autism-related symptoms had improved
even further (Kang et al., 2019). Moreover, the elevations in
Bifidobacterium and Prevotella remained (Kang et al., 2019). By
showing that some of the microbial changes were preserved
in the recipient gut even 2 years later, these results also
extend earlier findings that transferred faecal microbes can
survive in the recipient for at least a few months
(Li et al., 2016).
These results suggest that the human microbiome may
serve as a therapeutic target in the treatment of autism.
However, placebo-controlled, double-blind, randomised
trials with larger samples are required to better understand
the therapeutic potential of microbial transfers. In an ear-
lier article (Sarkar et al., 2018), we suggested that one rea-
son that microbiome transplants may yield greater
therapeutic efficacy for autism compared to psychobiotic
or antibiotic routes is the difference in scale: the number
of microbes that can be introduced into a new host via fae-
cal transfers is many orders of magnitude greater than pro-
biotic consumption. Typical probiotic doses can only
introduce a comparatively small number of microbes into
the gut, and, as discussed earlier, these are often unsuccess-
ful in colonising the new host. Furthermore, in comparison
to probiotic treatment, which typically involves the admin-
istration of only one or a few bacterial strains, a faecal
transfer can introduce an entire bacterial community into
the recipient’s gut.
Of course, while these results (Kang et al., 2017, 2019) are
promising, the small initial sample size (N = 18), the open-
label nature of the design, and the lack of a control group
all pose substantial challenges to the generalisability and
applicability of these results. For example, a small sample
size combined with a high degree of variance can often result
in an overestimation of the true effect size (Gelman &Carlin,
2014). Thus, it may be that even if this approach yields ther-
apeutic benefits for autistic individuals, the average
improvement may be smaller than that observed in this
sample.
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(6) Statistical power, replication, and causal
evidence
As noted elsewhere (Forsythe et al., 2016; Sarkar et al., 2018),
human research on the link between the microbiome and
psychological processes is fraught with noise arising from var-
iations in genetics, sex, age, diet, past and present environ-
mental exposures, and use of medicines, all of which can be
strictly controlled in laboratory-based rodent studies. While
some of the stress- and emotion-related findings in humans
resemble rodent findings in several respects, they have much
lower statistical power. Moreover, some experiments and
meta-analyses have not found consistent psychological effects
of probiotic consumption (Romijn & Rucklidge, 2015; Kelly
et al., 2017; Romijn et al., 2017). Overall, while many of these
findings are promising, they must also be viewed as prelimi-
nary, and highlight the need to examine the psychological
and social effects of intrinsic microbial variation and exoge-
nous microbial manipulation in larger and more diverse
samples.
In general, there is limited evidence that the results
obtained in one study will be reliably replicated in subse-
quent studies. This is especially true for the neuroimaging
research we have described here. Given the relatively small
sample sizes in these reports, alongside the known prevalence
of very low statistical power in cognitive neuroscience and
brain-imaging research (Button et al., 2013; Szucs & Ioanni-
dis, 2017), it may be that many of the most intriguing
microbiome–brain associations in humans are false positives.
Thus, until replications have been conducted, it would be
prudent to be at most cautiously optimistic about these
associations.
It should also be kept in mind that these findings are
instances of correlation (in many cases with low statistical
power to detect effects). While causal speculation is of course
permissible for the generation of hypotheses and design of
future studies (particularly in light of evidence from animal
research), most of the human findings do not provide any
direct evidence of causation.
IX. CONNECTING PHYSIOLOGY TO SOCIAL
BEHAVIOUR
(1) Two types of investigations
Investigations of microbiome-associated changes in the host that
are relevant to host social behaviour can broadly be placed in
one of two categories. The first category consists of studies that
analyse the effect of the microbiome (e.g. via germ-free animals
or antibiotic administration) on concentrations ofmolecules impli-
cated in social behaviour, or the structure and function of relevant
brain regions. However, social behaviour itself is frequently not
measured in these studies. For instance, the pronounced influence
of the microbiome on endogenous testosterone concentrations
(Markle et al., 2013) was discovered in the context of autoimmu-
nity, and the motivation for the research more broadly was the
immunosuppressive – not the social – effect of testosterone. The
second category comprises studies that investigatemicrobial effects
on social behaviour, and also examine microbial effects on host
physiology in parallel. However, in most cases, the relationships
between the behavioural and physiological effects uncovered by
these studies are correlational. Thus, it is often rather difficult to
interpret the direction of causality, or which biological changes
mediate the relationship between the microbiome and assays of
host social behaviour.
(2) Connecting the microbiome to social behaviour
There is limited research that conclusively identifies a biological
mediator of the relationship between the microbiome and host
sociality, although of course such mediators must exist. While it
is likely that the microbiome–sociality relationship is mediated,
at least in part, by changes in the anatomy and function of
regions in the social brain, or in the biosynthesis and bioavail-
ability of social signalling molecules, there are few studies that
have identified such underlying pathways from changes in the
microbiome to changes at the behavioural level.
Consider the involvement of the microbiome in autism. In
terms of the neurological basis of the microbiome–autism
connection, our current knowledge is based on adjacent links
in a chain. One link, supplied by microbiology and neurosci-
ence, is the finding that the microbiome influences amygda-
lar structure and function (Luczynski et al., 2016; Hoban
et al., 2018). The second link, from cognitive neuroscience
and biological psychiatry, is the finding that variations in
amygdala structure and function may be involved in autism
(Baron-Cohen et al., 1999, 2000). However, these findings
cannot automatically be connected to infer that the amyg-
dala plays a role in the microbiome’s interactions with autism
in humans (or even in mice, for that matter). Indeed,
microbiome-associated changes in the amygdala may only
share minimal overlap with autism-associated changes in
the amygdala. Therefore, at best, the current set of findings
permits the possibility that a microbiome ! amygdala !
autism connection may exist and could be subject to future
investigation.
Similarly, consider the example of testosterone. One link
in the chain is that the microbiome affects testosterone, and
the adjacent link, supplied by behavioural endocrinology, is
that testosterone affects animal social behaviour. In rodents,
this would likely manifest as aggression. But there is as yet no
report of a microbiome ! testosterone ! aggression con-
nection in rodents. Until evidence of such a link is generated,
we cannot know whether microbial effects on testosterone
actually influence social behaviour. Even when the micro-
biome does influence testosterone bioavailability, the hor-
mone may not necessarily affect behaviour, since there are
many different physiological actions of testosterone, some
of which may have no significant behavioural correlates. Fur-
thermore, it is important to keep inmind that all of these mol-
ecules (neurotransmitters, steroids, and neuropeptides)
perform numerous physiological functions for the host, and
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Fig. 6. Models of the order of microbial effects on host social behaviour. Germ-free models, as well as studies involving antibiotic
administration or disruptions to maternal physiology during pregnancy, have revealed the important contributions of the
microbiome to host development in rodents. However, because many of the specific mechanisms by which microbes influence host
physiological development are unknown, it is currently not possible to establish the order of these effects, and how they in turn
affect social behaviour. This gives rise to several hypotheses about how these processes occur in relation to one another. (A) The
microbiome influences the immune system, metabolism, and the brain independently, with microbial effects on the immune
system and metabolism having little or no effect on the brain and social behaviour. (B) A sequential model in which a particular
developmental sequence leads to the microbiome ultimately affecting host social behaviour. The microbiome influences the
development of a single function, which in turn influences a second function, and so on. A and B are unlikely to occur in reality,
but may represent useful null models for the generation of predictions and comparisons. (C) An interactive model which assumes
(Figure legend continues on next page.)
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variations in their bioavailability cannot be assumed to exert
psychological effects on the host.
(3) Linking microbes to social behaviour via a
biological mediator
To further our understanding of the microbiome–sociality
connection, explicit investigations are required into how the
physiological changes induced by the microbiome influence
behaviour. The investigation of the microbiome–autism con-
nection by Kim et al. (2017) is an example in this regard. The
researchers found that the presence of segmented filamen-
tous bacteria in the maternal gut is necessary for maternal
immune activation to trigger autistic-like traits in the off-
spring. These findings reveal mechanistic connections
between the maternal microbiome and offspring social
behaviour that are mediated by the action of interleukin-
17a secreted by maternal TH17 cells.
Another example is the finding that Lactobacillus reuteri only
ameliorates social deficits in mice with functioning oxytocin
systems, as conditional deletion of oxytocin receptors in neu-
rons in the ventral tegmental area prevented Lactobacillus reu-
teri treatment from rescuing social impairments (Sgritta et al.,
2019). Therefore, this experiment provides valuable evi-
dence of a bacterium ! oxytocin ! social behaviour rela-
tionship. This type of investigation helps connect bacteria
to behaviour via a likely physiological mediator (oxytocin),
thereby providing evidence of a causal pathway. Of course,
the causal pathway itself will be substantially more complex
than this, involving a number of other signalling molecules
and components (e.g. the vagus nerve), but at the very least,
we can begin to consider how a social signalling molecule
plays a role in the microbiome–sociality relationship.
(4) Other signalling molecules
In this article, we have focussed mainly on a specific set of
molecules that have well-documented effects on social behav-
iour. However, the microbiome regulates a wide range of
other molecules and some of these may also influence animal
social behaviour. For instance, researchers have recently
found evidence suggesting that the proinflammatory cytokine
interferon-γ may play a role in social behaviour across the
animal kingdom (Filiano et al., 2016). They hypothesise that
this link between interferon-γ and social behaviour may have
arisen over evolutionary time during the transition to social-
ity since group living may have favoured a stronger immune
response to protect organisms from pathogens transmitted by
conspecifics (Filiano et al., 2016). Some probiotics are able to
alter the concentrations of interferon-γ, as well as other
proinflammatory cytokines (Desbonnet et al., 2008; Donato
et al., 2010; Rodrigues et al., 2012). While it is presently
unknown whether microbiome-related variations in cyto-
kines can affect social behaviour, the discovery of central
lymphatic vessels that could deliver immune molecules to
the brain suggests that the connection between the immune
system and the brain is more direct that previously thought
(Louveau et al., 2015). Given the relationship between the
microbiome and the immune system (Round &Mazmanian,
2009; Fung et al., 2017) as well as between the immune system
and social behaviour (Eisenberger et al., 2017), it is at least
conceivable that some of the microbiome–sociality connec-
tions may be mediated by immune molecules.
X. UNDERSTANDING THEORDER AND NATURE
OF MICROBIAL EFFECTS ON HOST SOCIALITY
Since the specific mechanisms by which the microbiome
influences host physiology remain poorly understood, an
important and currently unresolved question is the order of
microbial effects on host social development and behaviour
(see Fig. 6). Germ-free status has been linked to many physi-
ological impairments, supporting the claim that microbes are
essential for normal development. Since animal life evolved
in the presence of microbes, it can be expected that a total
absence of microbes would alter normal physiology
(McFall-Ngai et al., 2013). Indeed, it is difficult to overstate
the extent of dysfunction in germ-free animals, including
supressed angiogenesis (Stappenbeck, Hooper, & Gordon,
2002), abnormal stress reactions (Sudo et al., 2004), abnormal
immune development (Olszak et al., 2012), abnormal devel-
opment of the enteric nervous system (McVey Neufeld
et al., 2013), excessive permeability of the blood–brain barrier
(Braniste et al., 2014), and abnormal brain development
(Diaz Heijtz et al., 2011; Hoban et al., 2016, 2017; Luczynski
et al., 2016).
Despite the many deficits of germ-free animals, it is not
known how the numerous microbial effects on host
(Figure legend continued from previous page.)
that the microbiomemakes core, parallel contributions to host metabolism and immunity that interact with one another, and which in
turn influence brain development and function, contributing to the host’s social behaviour (in this case, effects on the brain follow
sequentially from changes in host metabolism and immunity). (D) An interactive hybrid model. Apart from microbial effects on the
brain via immunological and metabolic influences, brain development may also be affected by the microbiome more directly,
perhaps via modulation of the vagus nerve or enteric nervous system. These models are highly simplified, and represent merely
four possibilities. Many other combinations are of course possible, and may involve other physiological systems including the
endocrine system and the olfactory system. Although this diagram only shows microbial effects on host physiological functions, the
relationships are bidirectional, with the host’s metabolism, immunity, brain, and social behaviour exerting effects on the
microbiome as well.
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physiological, psychological, and social development are
connected to one another. Are microbial contributions to
social behaviour purely reflective of what may be considered
their core contributions to metabolic and immunological
development? Perhaps the changes in one function are in fact
caused by changes in another function, and may in turn trig-
ger further changes. Or is it that microbial effects on neuro-
transmitters, brain circuitry, the endocrine system, and the
olfactory system, all of which play key roles in sociality, arise
independently of microbial regulation of host metabolism
and immunity? This latter proposition is unlikely, but may
have some utility as a point of comparison for more probable
models. Researchers face significant challenges – and oppor-
tunities – in establishing the causal order of bacterial contri-
butions to host physiological development, and this in turn
will allow for more precise examination of microbial contri-
butions to social behaviour. For example, to investigate the
overall influence of the microbiome on social behaviour,
researchers could longitudinally administer a battery of phys-
iological and social tests to germ-free mice colonised at differ-
ent ages with microbiomes from healthy and socially atypical
conspecifics. Researchers could also administer the same
physiological and social tests to conventional mice treated
with broad-spectrum antibiotics and compare the results to
the control group with matched ages. Then the microbiomes
of a subset of these antibiotic-treated micemight be ‘restored’
via transplants from socially normal versus socially atypical
conspecifics to gain insight into the extent to which physiol-
ogy and social behaviour are transmissible via the micro-
biome, given an initially healthy phenotype.
XI. CONCLUSIONS
(1) The microbiome affects animal social behaviour, but
the specific biological pathways that mediate these
associations are yet to be fully elucidated.
(2) There is evidence that changes in the gut microbiome
can lead to changes in the structure and function of
the social brain, influence various neurochemicals,
and alter genetic and epigenetic processes.
(3) Microbiome–sociality associations include relation-
ships between the microbiome and social stress, social
interaction, and autistic phenotypes.
(4) The microbiome affects the development and
function of regions of the social brain, including the
amygdala, prefrontal cortex, hippocampus, and
hypothalamus.
(5) The microbiome influences the concentrations and
signalling properties of a variety of molecules that
play an important role in social behaviour (i.e., social
signalling molecules), including glucocorticoids such
as cortisol and corticosterone, sex steroids such as tes-
tosterone, oestradiol, and progesterone, neuropep-
tides such as oxytocin and vasopressin, and
monoamines such as serotonin and dopamine.
(6) The microbiome is associated with changes in RNA
biology and gene expression that may relate to host
social behaviour.
(7) The microbiome generates a range of olfactory sig-
nalling molecules (odourants) that can bind to olfac-
tory receptors distributed throughout the host’s
body. This microbiome–olfaction–behaviour path-
way may play a more important role in host sociality
than is currently recognised. Microbially produced
signalling molecules also influence host social interac-
tions with conspecifics in both insects and mammals
via the regulation of host odour profiles and scent-
based markings (e.g. urine, faeces, and paste).
(8) Observational and psychobiotic studies in humans
suggest that the microbiome is involved in human
emotional processes as well. Several psychobiotics
appear to be beneficial in reducing negative emotions
in humans. Researchers have also detected correla-
tions between microbial composition and depression,
although the functional role of bacteria in depression
remains largely unknown. The microbiome in early
infancy may also play a role in the development of
social and emotional traits, and may even influence
individual susceptibility to developing autism. At the
same time, human microbiome research is typically
underpowered and the data are characterised by a
great deal of variation. Perhaps because of this, stud-
ies investigating the relationship between the human
gut microbiome and psychology sometimes report
inconsistent findings.
(9) There is limited direct evidence connecting the
microbiome to a specific social behaviour via a physi-
ological mediator. As such, designing experiments to
examine these links should be prioritised in future
research.
(10) It will be important to understand the order of micro-
bial effects on host sociality, since the microbiome
affects multiple aspects of physiology, including the
nervous system, metabolism, and immunity.
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HIBBERD, M. L., FORSSBERG, H. & PETTERSSON, S. (2011). Normal gut microbiota
modulates brain development and behavior. Proceedings of the National Academy of
Sciences of the United States of America 108, 3047–3052.
DICKERSON, S. S. & KEMENY, M. E. (2004). Acute stressors and cortisol responses: a
theoretical integration and synthesis of laboratory research. Psychological Bulletin
130, 355–391.
DILLON, R. J., VENNARD, C. T. & CHARNLEY, A. K. (2000). Pheromones: exploitation of
gut bacteria in the locust. Nature 403, 851.
DILLON, R. J., VENNARD, C. T. & CHARNLEY, A. K. (2002). A note: gut bacteria produce
components of a locust cohesion pheromone. Journal of Applied Microbiology 92,
759–763.
DINAN, T. G., STANTON, C. & CRYAN, J. F. (2013). Psychobiotics: a novel class of
psychotropic. Biological Psychiatry 74, 720–726.
DINAN, T. G., STILLING, R. M., STANTON, C. & CRYAN, J. F. (2015). Collective
unconscious: how gut microbes shape human behavior. Journal of Psychiatric Research
63, 1–9.
DOMINGUEZ-BELLO, M. G., COSTELLO, E. K., CONTRERAS, M., MAGRIS, M.,
HIDALGO, G., FIERER, N. & KNIGHT, R. (2010). Delivery mode shapes the
acquisition and structure of the initial microbiota across multiple body habitats in
newborns. Proceedings of the National Academy of Sciences of the United States of America
107, 11971–11975.
DONATO, K. A., GAREAU, M. G., WANG, Y. J. J. & SHERMAN, P. M. (2010). Lactobacillus
rhamnosus GG attenuates interferon-γ and tumour necrosis factor-α-induced barrier
dysfunction and pro-inflammatory signalling. Microbiology 156, 3288–3297.
DOSMANN, A., BAHET, N. & GORDON, D. M. (2016). Experimental modulation of
external microbiome affects nestmate recognition in harvester ants (Pogonomyrmex
barbatus). PeerJ 4, e1566.
DOWLATI, Y., HERRMANN, N., SWARDFAGER, W., LIU, H., SHAM, L., REIM, E. K. &
LANCTÔT, K. (2010). A meta-analysis of cytokines in major depression. Biological
Psychiatry 67, 446–457.
DREA, C. M.,VIGNIERI, S. N.,CUNNINGHAM, S. B.&GLICKMAN, S. E. (2002a). Responses
to olfactory stimuli in spotted hyenas (Crocuta crocuta): I. Investigation of
environmental odors and the function of rolling. Journal of Comparative Psychology
116, 331–341.
DREA, C. M., VIGNIERI, S. N., KIM, H. S., WELDELE, M. L. & GLICKMAN, S. E. (2002b).
Responses to olfactory stimuli in spotted hyenas (Crocuta crocuta): II. Discrimination of
conspecific scent. Journal of Comparative Psychology 116, 342–349.
DUNN, A. J. & FILE, S. E. (1987). Corticotropin-releasing factor has an anxiogenic
action in the social interaction test. Hormones and Behavior 21, 193–202.
DUNPHY-DOHERTY, F.,O’MAHONY, S. M., PETERSON, V. L.,O’SULLIVAN, O.,CRISPIE, F.,
COTTER, P. D., WIGMORE, P., KING, M. V., CRYAN, J. F. & FONE, K. C. (2018). Post-
weaning social isolation of rats leads to long-term disruption of the gut
microbiota–immune–brain axis. Brain, Behavior, and Immunity 68, 261–273.
ECKBURG, P. B., BIK, E. M., BERNSTEIN, C. N., PURDOM, E., DETHLEFSEN, L.,
SARGENT, M., GILL, S. R., NELSON, K. E. & RELMAN, D. A. (2005). Diversity of the
human intestinal microbial flora. Science 308, 1635–1638.
EISENBERGER, N. I., MOIENI, M., INAGAKI, T. K., MUSCATELL, K. A. & IRWIN, M. R.
(2017). In sickness and in health: the co-regulation of inflammation and social
behaviour. Neuropsychopharmacology 42, 242–253.
EISENEGGER, C., HAUSHOFER, J. & FEHR, E. (2011). The role of testosterone in social
interaction. Trends in Cognitive Sciences 15, 263–271.
EIWEGGER, T., STAHL, B., HAIDL, P., SCHMITT, J., BOEHM, G., DEHLINK, E.,
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ERIKSSON, H., GUSTAFSSON, J. Å. & SJÖVALL, J. (1969). Steroids in germfree and
conventional rats: free steroids in faeces from conventional rats. European Journal of
Biochemistry 9, 286–290.
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HAPPÉ, F.,RONALD, A.& PLOMIN, R. (2006). Time to give up on a single explanation for
autism. Nature Neuroscience 9, 1218–1220.
HASTINGS, R. S., PARSEY, R. V., OQUENDO, M. A., ARANGO, V. & MANN, J. J. (2004).
Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major
depression. Neuropsychopharmacology 29, 952–959.
HATA, T., ASANO, Y., YOSHIHARA, K., KIMURA-TODANI, T., MIYATA, N., ZHANG, X. T.,
TAKAKURA, S., AIBA, Y., KOGA, Y. & SUDO, N. (2017). Regulation of gut luminal
serotonin by commensal microbiota in mice. PLoS One 12, e0180745.
HAU,M. (2007). Regulation of male traits by testosterone: implications for the evolution
of vertebrate life histories. BioEssays 29, 133–144.
HECHLER, C., BOREWICZ, K., BEIJERS, R., SACCENTI, E., RIKSEN-WALRAVEN, M.,
SMIDT, H. & DE WEERTH, C. (2019). Association between psychosocial stress and
fecal microbiota in pregnant women. Scientific Reports 9, 4463.
HOBAN, A. E., STILLING, R. M., RYAN, F. J., SHANAHAN, F., DINAN, T. G.,
CLAESSON, M. J., CLARKE, G. & CRYAN, J. F. (2016). Regulation of prefrontal cortex
myelination by the microbiota. Translational Psychiatry 6, e774.
HOBAN, A. E., STILLING, R. M., MOLONEY, G. M., MOLONEY, R. D., SHANAHAN, F.,
DINAN, T. G., CRYAN, J. F. & CLARKE, G. (2017). Microbial regulation of
microRNA expression in the amygdala and prefrontal cortex. Microbiome 5, 102.
HOBAN, A. E., STILLING, R. M., MOLONEY, G., SHANAHAN, F., DINAN, T. G.,
CLARKE, G. & CRYAN, J. F. (2018). The microbiome regulates amygdala-dependent
fear recall. Molecular Psychiatry 23, 1134–1144.
HORVATH, K. & PERMAN, J. A. (2002). Autism and gastrointestinal symptoms. Current
Gastroenterology Reports 4, 251–258.
HOWE, M. W. & DOMBECK, D. A. (2016). Rapid signalling in distinct dopaminergic
axons during locomotion and reward. Nature 535, 505–510.
HSIAO, E. Y., MCBRIDE, S. W., HSIEN, S., SHARON, G., HYDE, E. R., MCCUE, T.,
CODELLI, J. A., CHOW, J., REISMAN, S. E., PETROSINO, J. F., PATTERSON, P. H. &
Biological Reviews 95 (2020) 1131–1166 © 2020 The Authors. Biological Reviews published by John Wiley & Sons Ltd on behalf of Cambridge Philosophical
Society.
The microbiome, neurobiology, and sociality 1161
MAZMANIAN, S. K. (2013). Microbiota modulate behavioral and physiological
abnormalities associated with neurodevelopmental disorders. Cell 155, 1451–1463.
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